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ABSTRACT	OF	THE	DISSERTATION	
Multi-contrast Photoacoustic Microscopy 
by 
Junjie Yao 
Doctor of Philosophy in Biomedical Engineering 
Washington University in St. Louis, 2012 
Professor Lihong V. Wang, Chairperson 
Photoacoustic microscopy is a hybrid imaging modality with high spatial resolution, moderate 
imaging depth, excellent imaging contrast and functional imaging capability. Taking full 
advantage of this powerful weapon, we have investigated different anatomical, functional, flow 
dynamic and metabolic parameter measurements using photoacoustic microscopy. Specifically, 
Evans-blue dye was used to enhance photoacoustic microscopy of capillaries; label-free 
transverse and axial blood flow was measured based on bandwidth broadening and time shift of 
the photoacoustic signals; metabolic rate of oxygen was quantified in vivo from all the five 
parameters measured by photoacoustic microcopy; whole cross-sectional imaging of small 
intestine was achieved on a double-illumination photoacoustic microscopy with extended depth 
of focus and imaging depth; hemodynamic imaging was performed on a MEMS-mirror enhanced 
photoacoustic microscopy with a cross-sectional imaging rate of 400 Hz. As a maturing imaging 
technique, PAM is expected to find new applications in both fundamental life science and 
clinical practice. 
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1.	Introduction	
For centuries, the development of optical microscopes has revolutionized fundamental life 
science and clinical practice [1]. By magnifying minuscule cellular and subcellular features, 
optical microscopes provide a powerful tool for studying tissue components and their dynamic 
interactions. Its excellent imaging contrast in soft tissue has made optical microscopy the most 
widely used imaging modality in the biomedical community [1].  
The visual power of optical microscopy relies on sharp optical focusing. Such power is rapidly 
reduced as photons travel deeper into biological tissue, a highly scattering medium for 
electromagnetic waves in the optical spectral range. When photons reach the optical diffusion 
limit (~1 mm in tissue), they have typically undergone tens of scattering events, which 
randomize the photon paths and thus prevent tight focusing [2]. Although modern optical 
microscopic techniques have released biologists from the confines of ten-micrometer-thick ex 
vivo tissue slices to a world of volumetric in vivo tissue, optical microscopy is still challenged to 
image at depths beyond the optical diffusion limit while maintaining high resolution. For decades, 
engineers have made scant progress by using pure optical approaches to fight scattering. 
Fortunately, the emerging technique of photoacoustic tomography (PAT) has pointed out a new 
direction, converting photon energy into ultrasound energy on the basis of the photoacoustic 
effect [3-14].  
In PAT, as photons travel in tissue, some of them are absorbed by biomolecules and their energy 
is partially or completely converted into heat. The heat then induces an initial pressure rise, 
which propagates in tissue as a wideband acoustic wave [15-17]. An ultrasonic transducer or 
transducer array detects the acoustic wave to form an image, which maps the original optical 
energy deposition in the tissue. Since ultrasonic scattering by tissue (~1.2 × 10-3 mm-1 in human 
skin at 5 MHz) [18] is more than three orders of magnitude weaker than optical scattering (~10 
mm-1 in human skin at 700 nm) [2], PAT can achieve fine acoustic resolution at depths beyond 
the optical diffusion limit. In addition, since the photoacoustic signal amplitude is proportional to 
the optical energy deposition, PAT is sensitive to the rich optical absorption contrast of tissue.  
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Several previous Review articles have given comprehensive coverage of PAT, focusing on 
instrumentation [4-6], contrast agents [8, 19], or biomedical applications [20-23]. The goal of 
this paper is to review a major implementation of PAT, photoacoustic microscopy (PAM). PAM 
has achieved spatial resolution ranging from sub-micrometer to sub-millimeter, at maximum 
imaging depths ranging from a few hundred micrometers to a few millimeters [3, 6]. Distinct 
from reconstruction-based PA computed tomography (PACT) [24-31], the other major 
implementation of PAT, PAM employs raster-scanning of optical and acoustic foci and forms 
images directly from acquired depth-resolved signals [3]. PAM maximizes its detection 
sensitivity by confocally aligning its optical illumination and acoustic detection. While the axial 
resolution of PAM is primarily determined by the imaging depth and the frequency response of 
the ultrasonic transducer, its lateral resolution is determined by the combined point spread 
function of the dual foci. PAM can be further classified into optical-resolution PAM (OR-PAM), 
where the optical focusing is much tighter than acoustic focusing [32], and acoustic-resolution 
PAM (AR-PAM), where the acoustic focusing is tighter [33, 34]. In addition, photoacoustic 
endoscopy (PAE) is considered as a variant of PAM for internal organ imaging, which is 
typically rotational scanning based. In PAM, while the depth-resolved acoustic waves render 1D 
PA images (A-scan), two-dimensional raster scanning generates 3D PA images (C-scan).  
In this dissertation, we will focus on the system construction and applications of OR-PAM. First, 
we will introduce the system characteristics of OR-PAM, including the spatial resolution, 
maximum imaging depth and imaging speed. Next, we will describe the different methods for 
oxygen saturation, flow speed and metabolic rate of oxygen measurements in multi-contrast OR-
PAM. Then, we will highlight the improvements of OR-PAM in its imaging depth and imaging 
speed. In the end, we envision future developments.  
2.	Optical‐resolution	photoacoustic	microscopy	
The scalability of PAM originates from its optical and acoustic focusing [3]. Within the optical 
diffusion limit, OR-PAM has a great advantage over AR-PAM in spatial resolution because the 
optical beam can be easily focused to a much tighter spot than the acoustic detection, owing to 
shorter optical wavelengths.  
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Figure	1.	Schematic	of	second‐generation	of	optical‐resolution	photoacoustic	microscopy	
Figure 1 shows a newly developed second-generation OR-PAM, which has shown a robust 
capability to non-invasively image microvasculature using endogenous contrast with high spatial 
resolution (lateral: ~5 µm; axial: ~15 µm) [32]. A  tunable dye laser (CBR-D, Sirah) pumped by 
a Nd:YLF laser (INNOSAB, Edgewave, 523 nm) serves as the light source. The laser pulse is 
reshaped by a 25-µm–diameter pinhole and focused onto the surface of the mouse ear by a 
microscope objective lens (Olympus 4×, NA=0.1) with a pulse energy of ~100 nJ. Ultrasonic 
detection is achieved through a spherically focused ultrasonic transducer (V2012-BC, 
Panametrics-NDT), which is placed confocally with the objective. The detected PA signal is then 
amplified, digitized, and saved. A volumetric image is generated by recording the time-resolved 
PA signal (A-line) at each horizontal location of the two-dimensional raster scan. The motion 
controller provides the trigger signals for laser firing, data acquisition, and motor scanning.  
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Since the acoustic focal diameter (~45 µm) is more than ten times as wide as the optical focal 
spot, the detection sensitivity within the optical focus is approximately uniform. Therefore, the 
lateral resolution of OR-PAM ,L ORR  is given by the diffraction-limited spot size of the optical 
focus [3, 35], 
 , 0.51 OL OR
O
R
NA
  (1) 
where O  is the optical wavelength and ONA  is the numerical aperture of the optical objective. 
The constant 0.51 reflects the full width at half maximum (FWHM) of the optical focal spot in 
light intensity. For a wavelength of 570 nm and an ONA  of 0.13, the lateral resolution of G2-OR-
PAM was experimentally determined to be 2.56 µm, which agrees to Eq. (1) [36]. This 
resolution is sufficient to resolve the cortical capillaries (diameter: 5-10 µm) of a nude mouse 
with the scalp removed but skull intact. From Eq. (1), the lateral resolution of OR-PAM can be 
scaled down by either increasing the objective ONA  or using a shorter excitation wavelength, 
with the maximum imaging depth scaled accordingly. 
It should be pointed out that the lateral resolution of OR-PAM is the finest at the depth 
corresponding to the focus of the optical objective for OR-PAM. At the two ends of the focal 
zone, the lateral resolution degrades by 2  due to diffraction. The focal zone for OR-PAM can 
be computed as 21.8 /OR O OZ NA . At the ends of twice the focal zone, the lateral resolution 
degrades by a factor of 2.  
The axial resolution of OR-PAM can be estimated by the formula, , / 0.88 /A OR AR A AR v f  , which 
is based on the assumption that the PA response to a point target follows a Gaussian frequency 
profile [3, 37]. Af  is the PA signal bandwidth, which can be approximated as the detection 
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bandwidth of the ultrasonic transducer and is often proportional to its central frequency Af . 
However, this is based on the assumption that the PA signal bandwidth is much wider than the 
detection bandwidth. As mentioned above, high-frequency components of acoustic waves are 
attenuated faster than low frequency ones, and thus, PA signal bandwidth decreases with 
imaging depth, resulting in worse axial resolution at greater depths. Using ultrasonic transducers 
with a central frequency of 50 MHz and a one-way -6 dB bandwidth of 100%, G2-OR-PAM in 
Figure 1 has achieved the same axial resolution of 15 m. 
The maximum imaging depth of OR-PAM is limited to ~1 mm in tissue due to optical scattering 
[36]. The optical attenuation by tissue includes both absorption and scattering [2]. Compared 
with absorption, scattering has a relatively weak dependence on wavelength. In general, an 
excitation wavelength within the tissue optical window around 700 nm helps achieve a deeper 
penetration because of the relatively low absorption of both hemoglobin and water, two major 
absorbers in tissue [2, 38]. As a gold standard, OR-PAM can achieve a depth-to-resolution ratio 
(DRR) of ~80. The DRR is defined as the ratio of the maximum imaging depth to the axial 
resolution, representing the number of resolution pixels in the depth dimension.    
As a high-resolution imaging modality, OR-PAM requires 2D raster scanning for 3D imaging. 
Compared with confocal microscopy and two-photon microscopy, PAM does not need depth 
scanning. Nonetheless, fast imaging speed is desirable to capture dynamics and eliminate motion 
artifacts caused by breathing and heart beating. The traditional OR-PAM systems with ball-
screw mechanical scanning have a typical cross-sectional (B-scan) scanning rate of 1 Hz [33-35]. 
This translates into an image acquisition time of 7 min for OR-PAM. Finer resolution PAM 
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systems, such as SW-PAM, need more pixels per unit area, resulting in an even longer data 
acquisition time [35].  
3.	Multi‐contrast	photoacoustic	microscopy	
Originating from optical absorption, photoacoustic signals can be used to derive a number of 
physical, chemical and functional parameters of the absorber and its microenvironment. Since a 
single parameter may not be able to fully reflect the true physiological and pathological 
conditions, multi-parameter PAM can provide a more comprehensive understanding, thus 
benefiting the diagnosis, staging and treatment of diseases.  
3.	1.	Photoacoustic	microscopy	of	capillaries	enhanced	by	Evans	blue	
Total concentration of hemoglobin (CHb) is the most commonly used blood perfusion index. At 
the isosbestic wavelengths of hemoglobin (e.g., 498 nm, 568 nm and 794 nm), the PA signal 
amplitude reflects the CHb distribution in relative values, regardless of the oxygenation level of 
hemoglobin  [39].  
However, RBC flow in capillaries is discontinuous and changes greatly over time [40-42]. 
Because RBCs are the only noticeable optical absorbers in capillaries, it is highly likely that no 
absorber is present in a particular voxel during the laser pulse, which results in discontinuous 
capillaries in a RBC-based PA image.  In order to acquire a complete capillary image and gain 
information about the capillary’s functional state[43], the use of an exogenic contrast agent is 
compelling.  
We use Evans Blue (EB) dye for this purpose. EB has strong absorption in visible and near-
infrared light, with a peak at 620 nm. EB is non-toxic and is used in measurement of blood 
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volume [44], lymph node location [45], microvascular permeability [46, 47], blood-retinal 
barrier breakdown [48], capillary perfusion [42] and blood plasma flow [40] among other 
applications. In the blood stream, EB mainly binds to serum albumin in a reversible manner, so it 
is uniformly distributed in the plasma, maximizing the chance to get a complete capillary 
network image. Under normal conditions, the EB-albumin (EBA) complex is confined to blood 
vessels, while the free dye more readily diffuses out into extravascular tissue. The diffused dye is 
bound to the surrounding tissue proteins, and finally cleared out by either metabolism or 
excretion [49-52]. 
3.1.1.	Methods	
Animal	preparation		
The ears of adult, 6- to 8-week-old nude mice (Hsd: Athymic Nude-FoxlNU, Harlan Co.; body 
weight: ~20 g) were used for all in vivo experiments here because their small thickness allowed 
us to verify some of the PA results by using a standard bright field optical microscope. The nude 
mouse ear model has a well-developed vasculature and has been widely used to study tumor 
angiogenesis and other microvascular diseases [53]. Before data acquisition, the animal was 
anaesthetized by an intraperitoneal injection of 85% ketamine and 15% xylazine (100 µl/g body 
weight). During data acquisition, the animal was placed on a warming pan (37ºC), and its head 
was held steady with a dental/hard palate fixture. The animal was kept still by using a breathing 
anesthesia system (E-Z Anesthesia, Euthanex). After experiment, the animal recovered naturally 
and was returned to its cage. All experimental animal procedures were carried out in conformity 
with the laboratory animal protocol approved by the Animal Studies Committee of School of 
Medicine at Washington University in St. Louis.  
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Mode	of	injection	of	EB		
A 6% or 3% EB w/v solution (Sigma, St. Louis, MO) was prepared by dilution of the dye in 
phosphate-buffered saline (PBS, pH 7.5). Before injection, the solution was filtered through a 5-
µm filter. An intravenous injection of EB was made to either of the dorsal veins of the tail. The 
injection lasted for about 10–20 seconds.  
3.1.2.	Results		
Spatially	continuous	capillary	imaging	using	EB	as	a	contrast	agent	
Two irradiation wavelengths 570 nm and 610 nm were chosen for RBC imaging and EB imaging, 
respectively. An area of 2 mm × 2 mm was chosen as the field of interest (FOI) near the margin 
of the nude mouse ear, where the capillary density was higher. Before the dye injection, control 
images were acquired with a scanning step size of 2.5 µm at 570 nm and 610 nm. The total 
scanning time for a complete volumetric data set was ~30 min for each wavelength. In order to 
get sufficient imaging contrast and sensitivity of the capillaries, a relatively high concentration of 
EB in the blood plasma should be reached. Here 0.2 mL of 6% EB solution was injected in a 
nude mouse (body weight: ~20 g). The total blood volume of the mouse was about 1.2 mL [54]. 
Thus the concentration of EB in the blood stream was ~1%, corresponding to an absorption 
coefficient of ~1000 cm-1 at 610 nm [55], which is ~20 times higher than that of blood (~50 cm-
1). Two PA images at 610 nm were acquired, one immediately after the dye injection and the 
other 30 min later. Transmission optical microscopic images at 4× magnification were acquired 
before and after injection.   
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Figure	 2.	 	 EB	 enhanced	 photoacoustic	 imaging	 of	 mouse	 ear	 microvessels.	 (a,	 b)	 PA	microvascular	 image	
before	 dye	 injection	 acquired	 at	 570	 nm	 (a)	 and	 at	 610	 nm	 (b).	 Arrows	 in	 (a)	 point	 to	 the	 fragmentary	
capillaries.	(c)	PA	image	acquired	at	610	nm	right	after	EB	(6%,	0.2	mL)	injection	via	tail	vein.	Arrows	in	(c)	
point	 to	 the	continuous	capillaries.	 (d)	PA	 image	acquired	at	610	nm	acquired	30	min	after	 injection.	 (e,	 f)	
Transmission	microscopic	images	of	the	same	area	before	(e)	and	after	(f)	injection.	Arrows	in	(d),	(e)	and	(f)	
point	to	sebaceous	glands.	All	the	photoacoustic	images	were	scaled	to	the	same	level	of	PA	signal.		
Before dye injection, a PA image was acquired at 570 nm. Hemoglobin has strong absorption at 
this wavelength, which provided high imaging contrast and a high signal to noise ratio (>40 dB). 
Veins and arteries larger than 10 µm in diameter contained a higher area density of RBCs and 
appeared uniformly bright. However, smaller capillaries, containing a single of RBCs, looked 
discontinuous and fragmentary. As a control, another image was acquired at 610 nm. The signal 
was very weak due to the low hemoglobin absorption at 610 nm, which was only one-twentieth 
of that at 570 nm. Right after the dye injection, the microvascular network appeared continuous 
as shown in Fig. 2c. Dense capillaries could be observed, as indicated by arrows. All the 
capillaries appear ‘broken’ in Fig. 2a became smooth and continuous. Moreover, the capillary 
branching points that were invisible in Fig. 2a could be clearly distinguished.  The blood vessels 
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in Fig. 2c appear somewhat thicker than those in Fig. 2a, which was possibly because the plasma 
volume was larger than the RBC volume. The discernable blood vessel volume in the plasma-
based image appeared to be more than 50% greater than that disclosed in the RBC-based image. 
The image in Fig. 2d was acquired at 610 nm 30 min after dye injection. It shows that a 
considerable amount of EB had diffused out of the blood vessels into the surrounding tissue but 
did not diffuse into the sebaceous glands, which appear as brown patches in the transmission 
microscopic images.  
Dynamics	of	EB	diffusion	out	of	the	blood	stream	
EB is removed from the vascular system principally by diffusing into extravascular tissue. At 
high dye concentrations, in the first few hours, it is mainly the free EB rather than the EB-
albumin complex that diffuses out. The fixation of the free EB molecules by tissue proteins 
causes more dye to leave the blood to maintain chemical equilibrium, until the tissue proteins 
become saturated [49-52, 56]. To better understand the diffusion dynamics, we monitored the 
dye diffusion over time and quantified the diffused dye volume in the tissue. Here, a smaller area 
of 1 mm × 1 mm was imaged near the margin of the nude mouse ear, so more data sets could be 
acquired over time due to the shorter scanning time of ~10 min. Control images at 570 nm and 
610 nm were acquired before dye injection. After  0.1 mL of 6% EB solution was injected, the 
dye molar concentration in the plasma was ~0.52 mM, which was a high concentration compared 
with the combination capability of albumin [52]. Right after injection, serial images at 610 nm 
were acquired every 20 min until the dye diffusion was observed to have reached saturation.  
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Figure	3.	Dynamics	of	EB	diffusion	out	of	the	blood	stream	into	surrounding	tissue.	(a,	b)	PA	images	acquired	
before	EB	injection	at	570	nm	(a)	and	at	610	nm	(b).	(c)‐(g)	PA	images	acquired	at	610	nm	after	EB	(6%,	0.1	
mL)	 injection	 at	 different	 times.	 (h)	 Partial	 volume	of	 EB	diffused	 into	 surrounding	 tissue.	 An	 exponential	
recovery	model	was	used	to	 fit	 the	experiment	data.	All	 the	photoacoustic	 images	were	scaled	 to	 the	same	
level.	
As before, control images at 570 nm and 610 nm were acquired before dye injection (Fig. 3a and 
3b). The whole microvascular network within the field of view showed up with denser and more 
continuous capillaries right after the 0.1 mL of 6% EB solution was injected (Fig. 3c). Sequential 
images were acquired at different time points from 30 min to 120 min (Figs. 3d-g). The partial 
volume of the free EB molecule diffused into extravascular tissue increased gradually and 
reached a plateau after ~2 hours. If the dye left the blood vessels in a passive diffusion pattern,  
the extravascular dye volume could be fitted by an exponential recovery model [57].  
 ( ) [1 exp( )]T eQ t Q kt    (2) 
where ( )TQ t , eQ  are the dye volumes at time t  and equilibrium, respectively, and k is the dye 
diffusion rate. The fit result shows that EB indeed diffused in a passive pattern (Fig. 3h). 
However, EB did not diffuse into the sebaceous glands, so more and more ‘dark cavities’ were 
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formed as the diffusion went on. Blood vessels were embedded in the diffused dye and 
capillaries became nearly invisible.  
Dynamics	of	the	EBA	clearance		
At low dye concentrations, EB exists almost exclusively in the form of EBA [52]. EB permeates 
wherever albumin is present. Therefore, the clearance dynamics of the EBA may be used to 
estimate the albumin metabolic rate in tissue [52].  
 
Figure	 4.	 Clearance	 dynamics	 of	 EBA.	 Before	 EB	 injection,	 (a)	 was	 acquired	 at	 610	 nm.	 On	 ½–10	 days	
following	EB	(3%,	0.05	mL)	injection,	images	(b)‐(i)	were	acquired	at	610	nm.	All	the	photoacoustic	images	
were	scaled	to	the	same	level.	
To better understand the clearance dynamics, in our work the EBA volume in the tissue was 
monitored by PA imaging. An imaging area of 1 mm × 1mm was chosen on the nude mouse ear, 
and control images at 570 nm and 610 nm were acquired before dye injection. Then 0.05 mL of 3% 
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EB solution was injected via the tail vein. Serial images were acquired at 610 nm every one or 
two days, until EBA had nearly completely cleared out.  
Before dye injection, Fig. 4a was acquired at 610 nm as a control image. Fig. 4b–i were acquired 
on different days after dye injection. The EBA volume out of the blood vessels was calculated. 
Quantified clearance was shown in Fig. 5. The EBA volume in the extravascular tissue reached 
maximum on Day 3 and then decreased to the base line by Day 10.  
A two-compartment model was used to fit the EBA volume in the extravascular tissue.  
 
1
1 2
V
V
T
V T
dQ k Q
dt
dQ k Q k Q
dt
 
 
 (3) 
where VQ , TQ are the EBA volumes in the blood stream and extravascular tissue, respectively. 
1k is the diffusion rate of EBA from the blood stream into the extravascular tissue, and 2k is the 
clearance rate of EBA in the tissue. The results were consistent with the standard histological 
studies of long term EBA decline [56, 58]. 
 
Figure	5.	Quantitative	analysis	of	EBA	clearance.	After	EB	(3%,	0.05	mL)	injection,	the	diffused	EBA	volume	in	
the	 surrounding	 tissue	 reached	 maximum	 on	 Day	 3,	 and	 decayed	 to	 the	 baseline	 by	 Day	 10.	 A	 two‐
compartment	model	was	used	to	fit	the	experiment	data.	
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3.1.3.	Conclusions	and	discussion	
In this work, we demonstrate the feasibility of using Evans Blue dye as a contrast agent to 
enhance in vivo photoacoustic microvascular imaging. Complete and continuous microvascular 
networks especially capillaries were imaged with the contrast of EB. And as to our knowledge, it 
is the first time that PA imaging has been used to study the dynamics of EB diffusion and EBA 
clearance.  
The photobleaching of EB may be crucial for quantitative study. In a previous study [55] for a 
pulsed Nd:YAG laser (532 nm, 50 Hz, 14 ns pulse) and static 0.3% EB solution, photobleaching 
started after 1 min irradiation with an energy deposition of 20 mJ/pulse cm2. In our study, the 
energy pulse deposition was about 100 mJ/pulse cm2. However, the irradiation time was only 7 
ns at each imaging position, which is much shorter than the reported photobleaching exposure 
time. Therefore, the influence of photobleaching on the quantitative study can be ignored, and 
the possibility that the apparent clearance of the dye was caused by photobleaching can be 
excluded.    
At high EB concentrations, it is mainly the free dye that passively diffuses out of the blood 
vessels over tens of minutes. At low EB concentrations, as in most biological applications [40, 
45, 47, 58, 59], it is mainly the EBA that diffuses out of the blood vessels, and thus it is usually 
used as an indicator of the vessel leakage level. Our study was implemented under baseline 
conditions, where the blood vessel was leakage-resistant for albumin, so relatively high EB 
concentrations were used here to study the dynamics. However, a high contrast PA image does 
not depend on whether free EB dye or EBA caused dye diffusion into extravascular tissue. The 
key point here is that the potential application of PA imaging combined with EB for 
physiological and pathological studies has been well demonstrated. Moreover, to test the imaging 
15 
 
sensitivity, a commonly used EB injection dose (30 mg/kg body weight) was used. The diffused 
EBA can be clearly observed due to the high absorption contrast between the dye-protein 
complex and background tissue hence the imaging sensitivity is sufficient for the biological 
applications.  
It is interesting that EB and EBA did not diffuse into the sebaceous glands, where ‘dark cavities’ 
were formed in the PA images, possibly caused by the denser structure or the biochemical 
properties of the sebaceous glands. The physiological characteristics of sebaceous glands have 
been thoroughly studied [60]. PA imaging facilitated by EB can provide three-dimensional 
structural and functional information of sebaceous glands, which are very important growth 
indexes during carcinoma development. 
3.2.	Photoacoustic	microscopy	in	transverse	blood	flow	imaging	
Combining the spatial resolution of ultrasound imaging with the contrast of optical absorption in 
deep biological tissues, photoacoustic imaging has been widely used in high-sensitivity structural 
and functional imaging with micrometer-scale spatial resolution [26, 32, 33, 61]. It has also 
shown the potential for measuring blood flow [62-64]. Previously, photoacoustic Doppler (PAD) 
shift was observed from flowing particles illuminated by an intensity-modulated continuous-
wave (CW) laser beam [62, 63]. This physical phenomenon provides a basis for photoacoustic 
Doppler flowmetry in optically scattering media [62]. However, the sensitivity of this method 
depends mainly on the FFT time window, which limited the three-dimensional imaging speed 
[65]. Furthermore, because a CW excitation source was used without frequency chirping, depth 
could not be resolved. Like the other flowmetries based on the Doppler frequency shift, PAD 
flowmetry was sensitive to the Doppler flow angle. In PA imaging of microvascular networks, 
the transverse component of the flow is sometimes dominant.  When the Doppler angle 
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approaches 90º, the PAD frequency shift almost vanishes. Previous works in the fields of optical 
coherence tomography and ultrasound imaging have demonstrated the feasibility of using the 
bandwidth broadening to provide quantitative information on transverse flow [66-68]. However, 
in those works the flow direction could not be determined due to the symmetry of the optical 
objective or ultrasonic transducer.  In the current work, we propose a method to measure both the 
transverse flow speed based on bandwidth broadening and the flow direction based on 
bidirectional scanning.   
3.2.1.	Methods		
Sources of broadening include geometry, transit time, Brownian motion, velocity gradient and 
turbulence [62, 66]. The contribution of Brownian motion to the overall broadening has been 
shown to be small and consequently neglected [69]. The contributions of the velocity gradient 
and turbulence can be minimized if the spatial resolution is high enough. The contributions of 
transit time and geometry are equivalent within the focal region [70, 71]. and can be derived 
either from diffraction theory or beam-to-flow ray theory, as shown in Fig. 6 [67].  
The bandwidth, dB , is given by 
 0 02 sin sin sind
v v WB f f
c c F
   
,
 (4)  
where v  is the flow velocity; c  is the speed of sound;   is the Doppler angle;   is the aperture 
angle of the acoustic lens; and 0f , W , and F are the center frequency, the diameter, and the 
focus length of the ultrasonic transducer, respectively. The bandwidth is proportional to the 
transverse flow and is maximized when the Doppler angle is 90º.  
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Figure	6.	Probe‐beam	geometry	for	the	transverse	flow	measurement.	
 
Figure	7.	Sequential	A‐scans	used	to	calculate	the	bandwidth	broadening.	
Because the resultant photoacoustic wave induced by pulse-laser excitation was wide-band, we 
used the standard deviation of the sequential A-line scans to estimate the bandwidth broadening 
(Fig. 7) [72, 73]. The digitized PA signal ( )p t  was first passed through a digital bandpass filter 
to increase the signal-to-noise ratio. The complex function ( )p t  was determined by the Hilbert 
transformation from ( )p t . The bandwidth broadening is given by 
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 (5) 
where T is the time interval between sequential A-scans, n  is the number of sequential scans 
used to compute the standard deviation, and k is an experimentally determined constant factor 
associated with the imaging system [72, 73]. The structural information was provided by the 
envelope amplitude of each A-scan, and the flow information was provided by the bandwidth 
broadening computed from sequential A-scans.  
Here, it is necessary to point out that OR-PAM, where the RBC number within the tight optical 
focus is limited, differs from the acoustic-resolution PAM (AR-PAM). In AR-PAM where the 
acoustic focus provides the lateral resolution, the high RBC density may increase the difficulty to 
detect the signal fluctuation caused by RBC flow. This can be potentially solved using low 
concentration contrast agents, such as nanoparticles. The imaging depth then can be extended 
into the diffuse regime. The proposed method should work in both cases, and the difference is 
accounted for by k in Eq. (5).   
In the current imaging system, the sample was translated by the scanning motor. Hence, the 
bandwidth broadening was actually determined by the combination of the flow velocity and the 
motor scanning velocity (Fig. 8). Therefore, a bidirectional scanning was used to determine the 
flow direction. The motor first scanned with velocity mv 

, and then switched to velocity mv 

. 
mv 

 has the same value as mv 

 but in the opposite direction. The measured flow speeds under the 
two scanning directions are given by the combination speeds of the flow and the motor as 
follows: 
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where _f mv   and _f mv   are the measured speeds with motor-scanning velocities mv 

 and  mv 

, 
respectively; mv  is the motor scanning speed;   is the angle between mv 

 and the flow velocity 
fv
 , and cos  can be provided by structural PA imaging.  Solving for the flow speed gives 
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 (7) 
If _ _f m f mv v  , we get 90   and vice versa. Therefore, the flow direction can be determined. 
In case that _ _f m f mv v  , which means that the flow is perpendicular to the motor-scanning 
direction, the flow direction can be determined at other positions, because the flow path is 
usually nonlinear. 
 
Figure	8.	Bidirectional	scanning	to	determine	the	flow	direction.	
fv
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
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3.2.2.	Results	
Phantom	study	
A straight capillary tube (inner diameter: 260 µm) and a 0.1% solution of red-dyed particles 
(diameter: 6 µm) were used to study the dependence of the bandwidth on the flow velocity. The 
flow with speeds for 0 to 2.5 mm/s was controlled by a 1 mL syringe driven by a syringe pump 
and illuminated at 570 nm. Although the scan angle can be generalized, in this instance, the 
bidirectional scanning was along the tube ( 0   ). The flow direction was the same as mv  . 
In this experiment, we extracted the data from the center of the capillary (Fig. 9a, 90   ).  
When the flow velocity was zero, the bandwidth broadening was caused only by the motor 
scanning, no matter the scanning direction. When the scanning was in the same direction as the 
flow ( mv 

, square), the bandwidth increased as the flow speed increased. When the scanning was 
opposite to the flow ( mv 

, triangle), the bandwidth first decreased as the flow speed increased. 
However, when the flow speed exceeded the scanning speed, the bandwidth began to increase. 
The turning point indicated the motor-scanning speed mv . After subtraction of the contribution 
of the motor scanning, the bandwidth profiles at the speeds of 2.3 mm/s (circle) and 1.6 mm/s 
(square) are shown in Fig. 9b. A parabolic flow model was used to fit the experimental results 
(solid curves). Data points on the bottom half of the capillary tube (the right side of the plot) 
were fewer than on the upper half, because light penetration was limited.    
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Figure	 9.	 Photoacoustic	 flow	measurement	 on	microsphere	 phantom.	 (a)	 Bandwidth	 as	 a	 function	 of	 flow	
velocity	 with	 a	 bidirectional	 motor	 scanning	 speed	 of	 1.1	 mm/s	 and	 Doppler	 angle	 of	 90°.	 	 The	 motor	
scanning	direction	was	either	the	same	as	the	flow	direction	( mv 
 ,	square)	or	opposite	to	the	flow	direction	
( mv 
 ,	triangle).		Solid	curves,	theoretical	predictions	fitted	with	Eq.	(2).	Error	bar,	standard	error.	 	(b)	Flow	
profiles	at	flow	velocities	of	2.3	mm/s	(circle)	and	1.6	mm/s	(square),	after	subtraction	of	the	contribution	of	
the	motor	scanning.	Solid	curves,	fitted	parabolic	flow	profiles.	
A tube laid in a zigzag pattern was used to get the structural and flow information simultaneously. 
The flow speed was set to be 1.3 mm/s and the flow direction varied from segment to segment. 
Three adjacent segments of the tube, denoted as 1S , 2S  and 3S  in Fig. 10a, were imaged. The 
bidirectional scanning was along the longitudinal axis of these segments. The flow directions in 
1S  and 3S  were the same as mv 

 while the flow direction in 2S  was the same as mv 

. 
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Figure	10.	Photoacoustic	flow	imaging	of	microsphere	phantom.	(a)	A	transmission	optical	microscopy	image	
of	three	adjacent	segments	of	a	tube	laid	in	a	zigzag	pattern.	The	flow	directions	in	 1S 	and	 3S 	were	the	same	
as	 mv 
 ,	 and	 the	 flow	direction	 in	 2S 	was	 the	 same	as	 mv 
 .	 (b)	A	cross	 section	of	 the	structural	 image.	The	
approximate	position	of	 the	cross	section	 is	 indicated	by	 the	dashed	 line	 in	 (a).	The	scale	bar	 for	 (b)‐(e)	 is	
shown	in	(b).	(c)	The	bandwidth	image	when	the	motor	scanned	in	 mv 
 .	(d)	The	bandwidth	image	when	the	
motor	scanned	in	 mv 
 .	(e)	The	bandwidth	image	after	subtraction	of	the	contribution	of	the	motor	scanning.	
The	 positive	 flow	 (with	 the	 same	direction	 as	 mv 
 )	 is	 shown	 in	 red	 and	 the	 negative	 flow	 (with	 the	 same	
direction	as	 mv 
 )	is	shown	in	blue.	(f)	The	speed	profile	indicated	by	the	dashed	line	in	(e).	
One cross section of the PA structural image is shown in Fig. 10b, and the approximate position 
of the cross section is indicated by the dashed line in Fig. 10a. The measured bandwidths when 
the motor scanned in mv 

 and mv 

 were quantified, as shown in Figs. 10c and 10d, respectively. 
Because the flow directions in 1S  and 3S  were the same as mv 

, and the flow direction in 2S  was 
opposite to mv 

, the measured bandwidth in 1S  and 3S  was greater than that in 2S  when the 
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motor scanned in mv 

 (Fig. 10c). For the same reason, the measured bandwidth in 1S  and 3S  was 
smaller than that in 2S  when the motor scanned in mv 

 (Fig. 10d). After subtraction of the 
contribution of the motor scanning, the bandwidth in all three segments became similar (Fig. 
10e), which means that the flow speed within the tube was consistent. The positive flow (with 
the same direction as mv 

) is shown in red and the negative flow (with the same direction as mv 

) 
is shown in blue. The negative bandwidth is only used to indicate the flow direction. The 
calculated flow profile indicated by the dashed line in Fig. 10e is shown in Fig. 10f. At the 
boundary of the tube, the particle density and the flow speed were relatively low, which resulted 
in instability in the calculation. The signal from the tube wall also contributed to the calculation 
error.    
Animal	study	
In vivo experiment was performed on the ear of a 6-week-old mouse (Hsd:ND4, Swiss Webster; 
Harlan, Indianapolis, IN). A volumetric dataset was acquired at 560 nm and 570 nm under 
bidirectional scanning on a 2 mm × 1 mm area with a scanning speed of 0.75 mm/s and a step 
size of 0.625 µm. The motor speed vibration (< 5% of the scanning speed) can be ignored in our 
study. Before data acquisition, the animal was anaesthetized by an intraperitoneal injection with 
a dose of 87 mg/kg ketamine and 13 mg/kg xylazine, and kept still by using a breathing 
anesthesia system (E-Z Anesthesia, Euthanex). All experimental animal procedures were carried 
out in conformity with the laboratory animal protocol approved by Washington University in St. 
Louis. The PA signal acquired at 570 nm maps the total hemoglobin concentration, which 
provides structural information of the vasculature (Fig. 11a). The dual-wavelength measurements 
were used to calculate sO2 using a previously published method [74] (Fig. 11b). A trace of the 
averaged sO2 values along the main vascular trunk is shown in Fig. 12a.  
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Figure	11.	PA	imaging	of	sO2	and	blood	flow	in	a	mouse	ear.	(a)	MAP	image	of	structure.	Scale	bar	=	250	μm.	
(b)	MAP	 image	 of	 sO2	 by	measurements	 at	 560	nm	and	570	nm.	 (c)	MAP	 image	 of	 blood	 flow	 speed	with	
magnitude	only	based	on	the	Doppler	broadening	of	bandwidth.	(d)	MAP	image	of	blood	flow	velocity	with	
directions.	The	positive	and	negative	flow	directions	are	shown	in	pseudocolors.	
Bidirectional scanning measurements at 570 nm were used to calculate the Doppler broadening 
of bandwidth with eight sequential A-scans in one B-scan (Doppler angle: ~90 deg), which 
provided the transverse blood flow images (Figs. 11c-d). Because the heart of a mouse beats at 
up to ~8 Hz and the frame rate for B-scans was ~1 Hz, the bidirectional scans most likely caught 
different phases of the systole and diastole. To mitigate the variation of the measured speed and 
better determine the flow direction, we averaged over 3-by-3 pixels. The positive and negative 
flows are shown in red and blue, respectively. A trace of the averaged speeds along the main 
vascular trunk is shown in Fig. 12b. Velocity profile indicated by the dashed line in Fig. 11d is 
shown in Fig. 12c. The flow speeds decrease from mother vessels to daughter vessels. The flow 
directions can also help to distinguish arterioles from venules. The imaged vessels that flow 
blood away from the heart are arterioles (marked in red in Fig. 11d), while the imaged vessels 
that flow blood back to the heart are venules (marked in blue in Fig. 11d). This classification is 
consistent with the categorization based on the sO2 measurement as shown in Fig. 11b. 
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Saturation may exist here because the maximum measured speeds have reached the saturation 
point observed in the phantom study.   
 
Figure	12.	Quantitation	of	PA	 flow	measurement	 in	mouse	ear.	 (a)	Trace	of	SO2	values,	 averaged	along	 the	
main	vascular	trunk.	(b)	Trace	of	the	blood	flow	speeds,	averaged	along	the	main	vascular	trunk.	(c)	Velocity	
profile	of	the	blood	flow	indicated	by	the	dashed	line	in	Figure	11(d).				
	
Another experiment was performed on a stage-16 chicken embryo. The chicken embryo has been 
widely used as a model to study the relationship between hemodynamics and circulatory diseases 
[75]. For our study, since the chicken embryo has a relatively slow blood flow speed and heart 
beating rate [75], the time course of the blood flow can be sufficiently sampled without speed 
saturation. A chicken embryo was first removed from a fertile white leghorn chicken egg 
(Sunrise Farms, Catskill, NY) after approximate 60 h of incubation and then cultured in 
phosphate buffered saline (PH: ~7.0). Infrared light was applied to the embryo during the 
experiment to maintain its activity (Temperature: ~30 ºC).  
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Figure	13.	Blood	flow	measurement	in	a	chicken	embryo.	(a)	Left:	a	transmission	optical	microscopy	image	of	
a	chicken	embryo	(stage	16).	Scale	bar	=	2	mm.	Right:	a	region	of	interest	(~2	mm	×	2	mm)	imaged	at	a	higher	
magnification	 (×32).	 Scale	 bar	 =	 500	 µm.	 (b)	 A	 PA	 image	 of	 the	 same	 area.	 Scale	 bar	 =	 500	µm.	 (d)	 Time	
course	of	the	blood	flow	speed	at	the	position	indicated	by	the	cross	in	(b).		
	
A transmission optical microscopy image of the entire embryo was acquired (Fig. 13a, left). An 
area of ~2 mm × 2 mm around the right lateral vitelline vein was imaged at a higher 
magnification (Fig. 13a, right), and a PA image of the same area was acquired at 570 nm (Fig. 
13b). The time course of the flow speed at the center of a vessel, marked by a cross in Fig. 13b, 
was measured using eight sequential A-scans without motor scanning. The Doppler angle was 
~90 deg. The forward and backward flows are clearly observed (Fig. 13c). The measured flow 
speeds are consistent with those observed previously in ovo [75]. The opposite flow directions 
were confirmed using the optical microscopy. The spectral analysis of the time course indicates a 
heart beating rate of ~0.5 Hz, which is consistent with the visual observation.  
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3.2.3.	Conclusions	and	discussion	
In theory, the maximum measurable speed is ~7.4 mm/s, which is limited by the 2 kHz 
maximum laser repetition rate and the light focus diameter in our system. It can be improved by 
increasing the laser repetition rate or enlarging the light focal spot. Both the minimum 
measurable speed and the speed sensitivity are around 0.1 mm/s, which are determined by the 
signal-to-noise ratio (SNR), which can be improved by averaging multiple measurements. With 
motor scanning, small vessels may not have sufficient SNR to keep the speed sensitivity. This 
problem can be solved by increasing the A-scan repetition rate or switching to M-mode 
measurement. The latter, however, will lose the flow direction information.  
Bidirectional scanning can help to determine the flow direction along the scanning line. However, 
if fv
  is perpendicular to the scanning line, which gives _ _f m f mv v  , the direction cannot be 
determined. One solution is to determine the flow direction at other positions of the same blood 
vessel. Another solution is to use four-directional scanning, including back and forth scanning 
along two orthogonal scanning lines. All the flow directions can be covered at the expense of 
imaging time. 
3.3.	Photoacoustic	microscopy	in	total	blood	flow	imaging	
So far, photoacoustic flow measurements have focused on either the axial [76-79] or transverse 
[64, 80-83] component of the flow vector. However, to quantify the total flow vector, the 
Doppler angle (angle of the flow direction relative to the axis of the received acoustic wave) is 
needed. The Doppler angle can be estimated by tracing the vessel centerline either manually or 
automatically in a volumetric image. In practice, however, volumetric information is not always 
available, as in the case of M-mode imaging. In addition, despite the additional time required for 
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volumetric imaging, accurate estimation of the Doppler angle is challenging if the system's axial 
and lateral resolutions are too different. Here, using PAM, we propose a simple method for 
measuring total flow and the Doppler angle by combining the axial and transverse flow 
measurements. Briefly, the axial flow speed is estimated from the phase shift between 
consecutive Hilbert transformed pairs of A-lines [65]. The sign of the phase shift provides the 
axial flow direction. The transverse flow speed is quantified from the bandwidth broadening via 
the Fourier transformation of sequential A-lines [81]. The transverse flow direction can be 
measured by bi-directional scanning [81]. We first verified this method by flowing bovine blood 
in a plastic tube (inner diameter: 200 µm) at different total speeds (0–7.5 mm/s) and Doppler 
angles (30–330º). Then, in a mouse ear, we measured the total flow speed and Doppler angle in 
vivo.  
3.3.1.	Methods	
Inspired by previous work in ultrasound imaging [84] and optical coherence tomography [65], 
we use the following formula to compute the axial component  pixelwise: 
 va  12 
c
T
 
f 0
, (8) 
where  is the speed of sound in water (1500 m/s),  is the time interval between the two 
consecutive A-lines acquired in M-mode,  is the phase shift in each pixel between two 
consecutive A-lines, and  is the central frequency of an ultrasonic transducer. The phase shift 
 is quantified via the Hilbert transformation. The sign of  provides the axial flow direction, 
where positive  means a flow towards the ultrasonic transducer and vice versa. The axial flow 
va
c T

f0
 

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velocity  is related to the total flow velocity  through , where  is the Doppler 
angle (Fig. 6). 
It has also been demonstrated above that the transverse flow component , which equals 
, can be estimated based on Eq. (4) [66, 67, 81] . For a PAM system with confocal 
alignment but different optical and acoustic focal sizes,  in Eq. (4) mostly accounts for the 
discrepancy in the two foci. In the case of the optical-resolution PAM (OR-PAM) used in this 
study [32], shown in Fig. 1, where the optical focusing (~5 μm) is much tighter than the acoustic 
focusing (~45 μm),  mainly comes from the PA amplitude fluctuation caused by particles 
passing through the optical focal zone. Therefore,  is mostly determined by the beam geometry 
of the optical focusing and equals 0.02 here. Several other minor factors, such as Brownian 
motion, particle size and shape, and velocity distribution across the focal zone may contribute to 
. Since all these bandwidth broadening mechanisms have a linear dependence on the mean 
transverse velocity [76], their contributions can also be incorporated into . The transverse flow 
direction can be measured by bi-directional scanning, as long as the transverse flow is not 
perpendicular to the scanning line [81]. If the transverse flow has a positive projection along the 
positive scanning direction, we define it as a positive flow, and vice versa.  
From the axial and transverse flow components, the Doppler angle  can be derived as 
, which ranges from 0° to 360°. Since the inverse tangent covers angles ranging 
only from –90° to 90°,  needs to be adjusted according to the flow direction. In Matlab, 
function tan2 can be used instead of tan to account directly for the flow direction. The total flow 
speed  is computed by .  
va v )cos(v 
vt
)sin(v
k
Bd
k
Bd
k

  tan1(vt /va )

v v  va2 vt2
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3.3.2.	Results	
Phantom	study	
Defibrinated oxygenated bovine blood (B-A8775, Materials Bio, hematocrit: 44%) was used for 
the flow phantom. The blood flowed in a transparent plastic tube (508-001, Silastic, inner 
diameter ~200 µm), driven by a syringe pump (BSP-99M, Braintree Scientific) with a 5 mL 
syringe (Multifit; Becton, Dickinson & Co). Two experiments were performed using this 
phantom. First, by changing the pumping speed, the mean flow speed was adjusted from 0 to 7.5 
mm/s, with a step size of 0.25 mm/s, while the Doppler angle was fixed at 30º. Second, by 
mounting the tube on a goniometer stage (GN05, Thorlabs), the Doppler angle was adjusted from 
30º to 330º with a step size of 30º, while the mean total flow speed was fixed at 1.0 mm/s. If we 
take the blood density as 1060 kg/m3 and the blood viscosity as 3×10-3 kg/(m·s) at room 
temperature, the Reynolds number was estimated to be far less than 1. Therefore, the flow in the 
tube was considered to be laminar [85]. It is worth mentioning that the 1/e penetration depth of 
light at 590 nm in oxygenated blood is ~130 µm, which is greater than the radius of the plastic 
tube. 
In the phantom studies, 3200 consecutive A-lines were acquired at each position across the tube 
(M-mode). For axial flow measurement, each A-line was passed through a digital band-pass filter 
centered at 50 MHz, with a –6 dB bandwidth of 20%. A moving smoothing operation was then 
performed over each eight sequential A-lines to increase SNR. Fig. 14a is a typical M-mode 
image across the center of the tube, with a Doppler angle of 30° and mean total flow speed of 
1.25 mm/s. Fig. 14b shows three representative A-lines with a time interval of 3.3 ms. The axial 
flow speed profile was then calculated from the average phase shift between two consecutive A-
lines after each A-line was Hilbert transformed. For transverse flow measurement, the original 
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data without filtering was used. The transverse flow was quantified along the lateral direction at 
each depth, where the bandwidth was computed via the Fourier transformation [80, 81].  
 
Figure	14.	Total	flow	measurement	on	bovine	blood.	(a)	An	M‐mode	image	of	the	tube	with	a	Doppler	angle	of	
30°	and	mean	total	flow	speed	of	1.25	mm/s	after	passing	through	a	digital	filter.	The	dashed	lines	indicate	
the	top	and	bottom	boundaries	of	the	tube.	(b)	Three	representative	consecutive	A‐lines	with	a	time	interval	
of	3.3	ms,	where	t0	is	indicated	by	the	arrow	in	(a).	The	horizontal	dashed	lines	indicate	the	top	and	bottom	
boundaries	of	the	tube.	The	oblique	dashed	line	shows	the	phase	shifts	among	these	A‐lines.	
A laminar flow model was used to fit the flow speed profiles along the axial and transverse 
directions of the tube [86]:  
 . (9) 
Here,  and  are the transverse and axial coordinates, respective, (  , ) are the tube center 
coordinates,  is the tube radius, and  is the flow speed at the tube center. While ( , ) 
and  can be measured directly from the cross-sectional image of the tube,  is the unknown 
parameter to be fitted for. 
For the first phantom study, representative axial and transverse flow profiles calculated from Fig. 
14a are shown in Fig. 15a. The measured mean axial and transverse speeds were 1.10 ± 0.09 
2 2
0 0
max 2
( ) ( )( , ) (1 )x x z zv x z v
R
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mm/s and 0.65 ± 0.02 mm/s, respectively. The measured mean total flow speed is 1.28 ± 0.09 
mm/s, and the measured Doppler angle is 30.6 ± 3.0º, which agrees with the preset value of 30º. 
Fig. 15b shows the measured mean axial, transverse, and total flow speeds as well as the Doppler 
angle as a function of the preset speeds. The Doppler angle was not calculated at zero flow speed. 
From the results, the measured speeds agree well with the preset speeds, and the calculated 
Doppler angles average 31.0 ± 2.7º.  The speed measurement errors are less than 0.3 mm/s. 
 
Figure	15.	Quantification	of	total	flow	measurement	with	fixed	Doppler	angle.	(a)	Transverse	and	axial	speed	
profiles	 from	 Figure	 14(a).	 (b)	Measured	 transverse,	 axial,	 total	 flow	 speeds	 as	well	 as	 the	 Doppler	 angle	
versus	the	preset	total	flow	speed.	
For the second phantom study, Fig. 16a shows representative axial and transverse flow profiles 
with the same mean total flow speed of 1.0 mm/s but two different Doppler angles (60º and 70º). 
The weighted mean axial and transverse speeds at 60º measure 0.45 ± 0.03 mm/s and 0.80 ± 0.03 
mm/s, respectively, yielding a total flow speed of 0.92 ± 0.03 mm/s and a Doppler angle of 60.6 
± 1.9º. The weighted mean axial and transverse speeds at 70º measure 0.33 ± 0.02 mm/s and 0.92 
± 0.10 mm/s, respectively, yielding a total flow speed of 0.98 ± 0.09 mm/s and a Doppler angle 
of 70.3 ± 2.3º. Furthermore, the measured Doppler angles as a function of preset angles are 
shown in Fig. 16b, which shows good agreement, within 15º. 
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Figure	16.	Doppler	angle	measurement	on	the	bovine	blood	phantom.	(a)	Measured	speed	profiles	of	the	axial	
and	transverse	flow	along	the	depth	direction,	with	the	same	total	flow	speed	(mean:	1.0	mm/s)	but	different	
Doppler	angles	(60°	and	70°).	T:	transverse;	A:	axial.	(b)	Measured	Doppler	angles	as	the	function	of	preset	
values.		
Animal	experiment	
The left ear of an adult, 8-week-old nude mouse (Hsd: Athymic Nude-FoxlNU, Harlan Co.; body 
weight ~20 g) was imaged in vivo. During data acquisition, the animal was held steady with a 
dental/hard palate fixture, and kept still by using a breathing anesthesia system (E-Z Anesthesia, 
Euthanex). An area of 1.0×0.5 mm2 at the base of the ear was chosen for total flow measurement. 
A bi-directional scan was performed over this area to measure the transverse flow direction. 
Oxygen saturation was then imaged on the same area with 584 nm and 590 nm optical 
wavelengths. After the experiment, the animal recovered naturally and was returned to its cage. 
The flow processing for the in vivo experiment was the same as that for the phantom study, 
except that a 1.0×0.5 mm2 area instead of only a cross-section was imaged. The absolute CHb and 
sO2 were computed using the previously published acoustic spectral method [87] and multi-
wavelength method [88], respectively. 
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A typical artery-vein pair at the base of a nude mouse ear was imaged (Fig. 17a). The 
morphology indicates that the thicker vessel of the pair is the vein, which is confirmed by the sO2 
measurement (Fig. 18a). The volumetric rendering (Fig. 17b) shows that the Doppler angles of 
the artery and vein at the proximal ends were approximately 82.5º and 255.5º, respectively (Fig. 
17c).  
 
Figure	 17.	 Three‐dimensional	 PAM	 of	 a	 mouse	 ear.	 (a)	 Maximum	 amplitude	 projection	 of	 the	 total	
hemoglobin	 concentration	 image	 of	 an	 artery‐vein	 pair	 of	 the	 mouse	 ear.	 Scale	 bar:	 100	 μm.	 CHb:	 total	
hemoglobin	 concentration.	 (b)	 Volumetric	 rending	 of	 the	 same	 area	 as	 (a).	 Scale	 bar:	 100	 μm.	 (c)	 Sagittal	
cross‐section	images	of	the	artery	(top)	and	vein	(bottom),	indicated	by	the	dashed	and	solid	arrows	in	(b),	
respectively.	The	Doppler	angles	were	estimated	to	be	82.5°	and	78.5°,	respectively.	Scale	bar:	100	μm.	
The maximum projection of total flow speed is shown in Fig. 18b, where the artery has faster 
flow than the vein. The transverse speeds at the centers of the artery and vein were 3.9 ± 0.25 
mm/s and 1.1 ± 0.20 mm/s, respectively, as shown in Fig. 18c. The transverse flow directions 
show that the blood in the artery indeed flowed from the proximal end to the distal end, and 
flowed in the opposite direction in the vein. The axial speeds at the centers of the artery and vein 
were 0.9 ± 0.25 mm/s and 0.4 ± 0.02 mm/s, respectively, as shown in Fig. 18d. The axial flow 
directions show that the blood flowed towards the transducer in the artery, but away from the 
transducer in the vein. Based on the above information, the total flow speeds at the centers of the 
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artery and vein were 4.0 ± 0.25 mm/s and 1.2 ± 0.19 mm/s, respectively. The Doppler angles at 
the centers of the artery and vein were 77.0 ± 3.6º and 250.0 ± 3.5º, respectively, which were 
consistent with the measurements from the volumetric image. 
 
Figure	18.	Total	flow	measurement	in	mouse	ear.	(a)	sO2	image	of	the	same	area	as	that	in	Fig.	17.	(b)	Total	
flow	 speed	 image	 of	 the	 same	 area.	 (c)	 Transverse	 speed	 profiles	 along	 the	 dashed	 line	 in	 (b).	 Positive	
transverse	flow	direction:	from	left	to	right.	(d)	Axial	speed	profiles	along	the	depth	direction	at	the	centers	of	
the	 artery	 and	 vein,	 indicated	 by	 the	 arrows	 in	 (b).	 Positive	 axial	 flow	 direction:	 towards	 the	 ultrasonic	
transducer.			
3.3.3.	Conclusions	and	discussion	
We have demonstrated a method for measuring both total flow velocity and Doppler angle using 
PAM. By Combining blood flow information with other anatomical and functional parameters 
such as vessel cross-sections, CHb and sO2, we can quantify the metabolic rate of oxygen (MRO2) 
for cancer hypermetabolism studies [89]. The advantage of this method is simplicity: No system 
modification or additional data acquisition is required to use our existing PAM. Both the axial 
and transverse flow components are measured in M-mode. Collating the A-lines side by side 
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yields a 2D matrix. The axial direction of this matrix (column) is called the fast axis (depth), 
whereas the lateral direction (row) is called the slow axis (time). The columns are Hilbert 
transformed to compare the phases for the computation of the axial flow. The rows are Fourier 
transformed to quantify the bandwidth for the computation of the transverse flow.  
In general, both axial and transverse flow directions should be measured to determine the total 
flow direction. Because blood can only flow along the blood vessels, only one of the two 
directions is required to be measured as long as the blood vessel can be resolved precisely. 
However, when there is no axial flow and the transverse flow direction is perpendicular to the bi-
directional scanning, four-directional scanning is required. 
In theory, the maximum measurable axial and transverse flow speeds are 60.0 mm/s and 21.2 
mm/s, respectively, limited by the 3 kHz PRF [65, 78, 81]. The minimum measureable axial and 
transverse speeds are ~0.1 mm/s, determined by the PRF and SNR [78, 81, 90]. In our studies, 
since the PRF can be as slow as 1 Hz at the expense of imaging speed, it is the SNR that limits 
the minimum measureable speeds.  
3.4.	Photoacoustic	microscopy	in	metabolic	rate	of	oxygen	measurement	
The energy demand of mammals is met primarily by aerobic metabolism, producing 88% of 
ATP molecules [91]. Therefore, the metabolic rate of oxygen (MRO2) is an important indicator 
of tissue viability and functionality. It is known that nearly all cancers after the early stage are 
starved for oxygen (hypoxia) due to hypermetabolism and/or limited blood supply, regardless of 
their cellar origins [92]. In the presence of low oxygen pressure, highly malignant cancer cells 
survive and proliferate via glycolysis (anaerobic respiration, the Warburg effect). The presence 
of a large number of hypoxic regions within a tumor usually correlates with a poor prognosis 
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[91]. This metabolic phenotype has become the basis for tumor imaging by positron emission 
tomography (PET) using radioactively labeled oxygen. Many other pathological and 
physiological functions are also closely related to alterations of oxygen metabolism: examples 
include Alzheimer's disease [93], diabetes [94], burns [95], obstructive pulmonary disease [96], 
congestive heart failure [97], aging [98], sleeping [99], and physiologic challenges [100]. 
Therefore, an accurate measurement of MRO2 has the potential to provide a powerful tool for 
diagnosis and therapy of cancer and other diseases as well as for metabolism-related 
pathophysiological studies.    
Compared with other oxygenation indexes of tissue, i.e., oxygen saturation of hemoglobin (sO2) 
and partial oxygen pressure (pO2), MRO2 is superior because it directly reflects the rate of 
oxygen consumption instead of the static oxygen concentration [101]. If the region of interest has 
well-defined feeding and draining vessels, we have [5]  
  2 Hb 2 2 /MRO = sO sO .i in on in out ut outv vC A WA      (10) 
Here, subscripts in and out denote feeding and draining vessels, respectively.   is the oxygen 
binding capacity of hemoglobin and is usually taken as a constant (1.36 ml O2/gram hemoglobin) 
[102]. HbC  is the total hemoglobin concentration (in grams of hemoglobin/ml blood). sO2 is the 
average oxygen saturation (in %). A  is the cross-sectional area (in mm
2). v  is the average blood 
flow speed (in mm/s). W is the weight of the region of interest (in grams). While HbC can be 
estimated anywhere in the trunk vasculature, the other parameters must be measured locally.  
Presently, three primary imaging modalities are used to quantify MRO2 [5]. Among them, PET is 
most widely used in clinical practice. However, the need for injection or inhalation of 
radioactively labeled exogenous tracers results in a complex procedure with exposure to ionizing 
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radiation, limiting its usage [103]. Functional magnetic resonance imaging (fMRI) has also been 
intensively used for MRO2 study, especially in the brain. fMRI is limited to qualitative 
evaluation of only temporal changes in MRO2 and has difficulty in measuring both HbC  and 2sO  
[104]. It also must switch between different imaging protocols to measure 2sO  and v  [105, 106]. 
Moreover, both PET and fMRI are expensive. Diffuse optical tomography (DOT) is also capable 
of measuring MRO2 and is relatively inexpensive, but it relies on an approximate theoretical 
model or other techniques (e.g., Doppler ultrasound and laser Doppler) to provide blood flow 
information [107, 108]. Recently, DOT has been combined with diffuse correlation spectroscopy 
(DCS), which is capable of providing relative blood flow information [109]. Furthermore, due to 
their relatively poor spatial resolutions, PET, fMRI and DOT usually measure MRO2 averaged 
over a large volume [21].    
Here, we overcome these limitations by using photoacoustic microscopy.We demonstrated that 
all five anatomic, chemical and fluid-dynamic parameters for MRO2 quantification can be 
obtained in absolute units by mPAM alone in vivo. Specifically, All the parameters for MRO2 
quantification in Eq. (10) can be simultaneously obtained by mPAM. Specifically, anatomic 
parameters W  and A  are quantified from the structural mPAM image [74]; functional 
parameters HbC  and 2sO  are measured by laser excitation at two wavelengths [33, 74]; fluid-
dynamic parameter v  is estimated on the basis of photoacoustic bandwidth broadening of the 
PA signal induced by circulating red blood cells [80, 110]. The structural image acquisition time 
is ~25 min for a 4 mm × 4 mm region (~1 Hz frame rate) using single wavelength; the 
oxygenation image acquisition time is ~20 min for a 1 mm × 1 mm region using two 
wavelengths (~0.3 Hz frame rate); the flow speed acquisition time is ~5 min for a 0.5 mm cross-
sectional line using single wavelength.   
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To validate mPAM, first we studied the MRO2 responses to hyperthermia and cryotherapy, two 
common therapeutic techniques. Furthermore, mPAM was used to image melanoma and 
glioblastoma longitudinally, demonstrating its capability of early cancer detection. 
3.4.1.	Methods	
Animal model. The nude mouse ear is a good model for validating mPAM because of its 
similarity to human skin and lack of motion artifacts [111-113]. Each artery-vein pair (AVP) 
feeds a well-defined region while one pair at the base of the ear feeds the entire ear (Fig. 19) 
[114, 115]. Consequently, the MRO2 based on each AVP approximates the MRO2 of its supplied 
region.  
 
Figure	19.	mPAM	measurements	of	oxygen	saturation	(sO2)	and	blood	flow	on	four	orders	of	artery‐vein	pairs	
in	the	mouse	ear.	(a)	sO2	mapping	from	two	measurements	at	584	nm	and	590	nm.	Four	different	orders	of	
artery‐vein	pairs	are	 labeled.	Scale	bar:	125	µm.	(b)	Profiles	of	blood	flow	speed	across	vessels	of	different	
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orders	measured	along	the	dashed	lines	in	(a)	on	the	basis	of	PA	bandwidth	broadening	at	584	nm.	Generally,	
the	flow	speed	decreases	from	the	proximal	order	to	the	distal	order.	However,	it	also	depends	on	the	vessel	
diameter	as	a	result	of	the	conservation	of	total	flow.	Solid	circles:	experimental	data;	red	curves:	fit.	(c)	Mean	
sO2	versus	the	vessel	order,	quantified	along	the	centerline	of	each	vessel.	The	sO2	values	in	both	the	arteries	
and	veins	change	slightly	with	the	vessel	order,	especially	at	distal	branches.	This	is	probably	due	to	oxygen	
diffusion	 between	 the	 arteries	 and	 veins,	 and	 the	 inhomogeneous	 MRO2.	 (d)	 Blood	 flow	 rate	 (in	 µl/min)	
versus	 the	 vessel	 order,	 quantified	 from	 the	 flow	 speed	 profiles	 and	 vessel	 diameters.	 Blood	 flow	 in	 both	
arteries	and	veins	decreases	from	the	proximal	order	to	the	distal	order,	and	is	conserved	between	the	artery	
and	vein	of	the	same	order.	 	The	blood	fed	by	the	artery	is	mostly	drained	by	the	corresponding	vein	of	the	
same	order.		V:	vein;	A:	artery.		
Hyperthermia	experimental	protocol	
In the hyperthermia study, the animal’s temperature was regulated by adjusting the water 
temperature in the heating pad placed underneath its abdomen. The water was circulated by a 
water-bath system (ISOTEMP 9100, Fisher Scientific). A cotton layer between the heating pad 
and the animal skin buffered and homogenized the temperature change and thus protected the 
animal from burns. The room temperature was kept at 23 ºC. The animal’s skin temperature 
(SKT) was monitored on the dorsal pelvis by an attached electronic thermometer (Radio Shack, 
Cat. No. 63-854). Before the experiment, the SKT was adjusted to 31 ºC, which was used as the 
baseline. The experiment was divided into three periods. The animal was first monitored at 
baseline temperature for ~40 min (the resting period), then heated for ~30 min by increasing the 
heading pad to 50 ºC (the heating period), and lastly allowed to cool to baseline for ~100 min 
(the recovery period). The hemodynamic parameters were simultaneously measured on the 
principal artery-vein pair (AVP) using mPAM. Each measurement took ~6 min, and the whole 
experiment lasted for ~3 hrs. 
Tumor	cell	culture		
B16 mouse melanoma cells were obtained from the Tissue Culture and Support Center at the 
Washington University School of Medicine. The cells were maintained in Dulbecco’s modified 
Eagle medium (DMEM, Invitrogen, Carlsbad, CA) supplemented with 10% FBS and 1% P/S. 
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U87 MG human brain glioblastoma cells (HTB-14) were obtained from American Type Cell 
Culture (ATCC). The cells were maintained in Eagle’s Minimum Essential Medium (EMEM, 
Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS, ATCC) and 1% 
penicillin-streptavidin (P/S, Invitrogen). The cultures were performed at 37 °C and 5% CO2, and 
the cells were passaged weekly. 
Inoculation	of	tumor	cells	
In the tumor study, 0.01 ml of suspension containing ~0.5 million B16 melanoma cells or U87 
human glioblastoma cells was inoculated into the top skin layer in the left ear of a nude mouse, 
using a 0.3 ml syringe with a 29-gauge needle. The injection was usually located near the second 
order branch of the principal AVP above the cartilage. The tumor was allowed to grow and 
monitored for one to three weeks. A control measurement was performed before the tumor cell 
injection (day 0).  
Hemodynamics	measured	by	mPAM		
The hemodynamic parameters were monitored using mPAM on the principal AVP, which 
included vessel diameter, total hemoglobin concentration, oxygen saturation, blood flow 
direction, and flow speed.  
1. Vessel diameter. The vessel diameter was measured along a cross-section perpendicular 
to the vessel centerline. A threshold of two times the noise level was empirically set to 
separate the background and vessel. The transverse dimension of the vessel cross-section 
was taken as the vessel diameter D, in case the excitation light could not penetrate the 
whole vessel in the axial direction. Then the vessel cross-section area was calculated as 
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 2/ 2A D . Five adjacent cross-sections were measured, and the mean value of the 
principal vein was used for MRO2 calculation.  
2. Total hemoglobin concentration. Since oxy-hemoglobin and deoxy-hemoglobin have the 
same absorption coefficient at 584 nm, the PA signal amplitude is proportional to the 
total hemoglobin concentration regardless of the oxygen saturation level [116]. On the 
basis of a previous study [117], the total hemoglobin concentration was set to be 146.0 g/l 
at baseline temperature (the hyperthermia study) and on day 0 (the tumor and cryotherapy 
studies). The sequential data sets were calibrated accordingly. The averaged PA signal 
amplitude along the centerline of the principal vein was used for calculation. 
3. Oxygen saturation. The oxygen saturation (sO2) was measured using laser excitations at 
584 nm and 590 nm, respectively [33]. The relative change in molar extinction 
coefficient is ~58.4% for oxy-hemoglobin and 17.5% for deoxy-hemoglobin, respectively. 
Because the vessels studied here were big enough (> 50 μm) and the laser pulse energy 
was low (~100 nJ), the difference of penetration depth won’t affect the results much. The 
PA signal at each wavelength was normalized with the laser pulse energy, as monitored 
by a wavelength-calibrated photodiode. The averaged sO2 along the vessel centerline was 
used for MRO2 calculation. The PA image acquired at 584 nm was used as a mask on the 
sO2 image to remove the background noise. 
4. Blood flow direction. The blood flow direction was measured on the basis of 
photoacoustic bandwidth broadening with bidirectional motor scanning at 584 nm [80]. 
The laser repetition rate was 3 KHz, and the scanning step size was 0.625 µm. We used 
64 sequential A-lines to calculate the bandwidth broadening. If the blood flow had a 
positive projection along the positive scanning direction, we defined it as a positive flow, 
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and vice versa. The mPAM image acquired at 584 nm was used as a mask on the flow 
image to remove the background noise. 
5. Blood flow speed. To better estimate the flow speed, M-mode imaging at 584 nm was 
used to measure the bandwidth broadening across the vessel. The laser repetition rate was 
3 KHz, and 3200 A-lines were acquired at each position. The flow speed at each position 
was calculated on the basis of the bandwidth broadening. The average amplitude of the 
PA signal at each position was used as a mask on the speed profile to remove the 
background noise. The mean flow speed of the principal vein was used for MRO2 
calculation.   
Melanoma	volume	estimation	using	mPAM		
After data acquisition, the PA signal amplitude acquired at each optical wavelength was 
extracted through the Hilbert transformation. The tumor region was then separated from the 
surrounding blood vessels according to the mPAM image acquired at 605 nm, where melanin has 
much stronger absorption than blood. A threshold of 20% of the maximum signal amplitude was 
set to segment the tumor. Since it was challenging to penetrate through the whole tumor due to 
the high absorption of melanin, a 3D envelope of the tumor region was obtained from the surface 
signal instead. The volume of the tumor was then calculated by integrating the corresponding 
voxels enclosed by the envelope. All the image processing was conducted using the MATLAB 
Image Processing Toolbox (R2008a, MathWorks). 
Fitting	for	the	profile	of	blood	flow	speed		
A theoretical model was used to fit the profile of the blood flow speed across the vessel [86],  
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 0max( ) [1 ]
nx xv x v
R
        (11) 
Here, x  is the transverse location; 0x is the vessel center; R  is the vessel radius; maxv  is the flow 
speed at the vessel center; and n  is the power index that characterizes the flow profile (e.g., n
=2 for laminar flow).  While 0x  and R  can be measured directly from the mPAM images of the 
vessel structure, maxv  and n  are the unknown parameters to fit for.  
Statistical	analysis		
Quantitative data was expressed as mean ± s.e.m. The statistical test is a paired Student’s t-test 
(two-tailed with unequal variance), compared with the baseline levels (hyperthermia and 
cryotherapy studies) or day 0 (tumor studies). We considered a p-value less than 0.05 to be 
statistically significant. 
3.4.2.	Results	
MRO2	quantification	under	normothermia	
As an example, we measured the MRO2 of a mouse ear under normothermia. The animal’s 
temperature was regulated with a heating pad placed under its abdomen (skin temperature: 31 
˚C), a volumetric image was acquired using mPAM at 584 nm by scanning a 10 mm × 8 mm area 
containing the principal AVP (Fig. 20a). Because 584 nm is an isosbestic wavelength for 
hemoglobin, this image maps the concentration of total hemoglobin regardless of the oxygen 
saturation level. In addition, it measures the diameters of the principal AVP (artery: ~65 µm; 
vein: ~116 µm). Two PAM images acquired at 584 nm and 590 nm were then used to calculate 
2sO  (Fig. 20b) [74]. The vessels with high 2sO  values (>90%) are classified as arteries, whereas 
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the vessels with low 2sO  values (60–80%) are veins. The blood flow velocity was measured at 
584 nm using bi-directional scanning with a laser repetition rate of 3 KHz and a motor step size 
of 0.625 µm (Fig. 20c). The profile of flow speed across the principal AVP is shown in Fig. 20d. 
The artery and the vein have a mean flow speed of 5.5 mm/s and 1.8 mm/s, respectively, and the 
speed profiles are both approximately parabolic [86]. The weight of the mouse ear was computed 
by its volume in the 3D PA image, where the average specific weight was assumed to be 1.0 
g/ml [118]. From these measurements, the MRO2 of the mouse ear was estimated to be 0.23 
ml/100 g/min, which agrees with the data previously measured in humans [92].  
 
Figure	20.		Label‐free	quantification	of	metabolic	rate	of	oxygen	(MRO2)	in	vivo.	(a)	mPAM	image	of	the	total	
concentration	 of	 hemoglobin	 (CHb).	 Scale	 bar:	 500	 µm.	 (b)	 mPAM	 image	 of	 the	 oxygen	 saturation	 of	
hemoglobin	(sO2)	in	the	area	indicated	by	the	dashed	box	in	(a).	Scale	bar:	125	µm.	(c)	mPAM	image	of	blood	
flow	 in	 the	 area	 indicated	 by	 the	 dashed	 box	 in	 (b).	 Red	 arrow:	 positive	 scanning	 direction;	 blue	 arrow:	
negative	scanning	direction.	Positive	velocity:	upward	flow.	Scale	bar:	125	µm.	(d)	Profile	of	blood	flow	speed	
across	the	dashed	line	in	(c).				
Change	in	MRO2	induced	by	systemic	hyperthermia	
Hyperthermia has been clinically used for cancer treatment [119]. To measure MRO2 during 
hyperthermia, the mouse’s skin temperature was elevated to 42 ºC (Fig. 21a). Hemodynamics 
were monitored on the principal AVP. The vessel diameter started increasing at the beginning of 
the heating period (Fig. 21b), and reached a maximum by the end of the heating period. The total 
hemoglobin concentration of the principal AVP kept increasing after the heating started, and 
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plateaued when the temperature returned to the baseline (Fig. 21c). This cumulative effect was 
due to a decrease in blood plasma volume resulting from water loss during hyperthermia [120]. 
From the change in sO2 (Fig. 21d), we found that the oxygen extraction fraction (OEF, defined 
as  2 2 2sO s /O sOin out in  and represents the fraction of O2 molecules that cross the capillary wall) 
decreased by 12% over the heating period and eventually recovered to 99% of the resting level 
(Fig. 21f). The measurements of flow speed in the arteries during the heating were saturated 
because of the limited maximum measurable speed of the system (Fig. 21e). From the 
measurements on the principal veins, we found the volumetric flow rate of blood entering the ear 
increased by 45%. Increased cardiac output and redistribution of blood to the skin are two major 
reasons for vessel dilation and faster blood flow, which help accelerate heat exchange with the 
environment [119, 121]. Note that the vessel diameter, sO2, and blood flow speed reach the 
peaks approximately simultaneously. 
The MRO2 of the mouse ear, as computed from the hemodynamic changes, increased by 28% 
over the heating period (Fig. 21f), which indicated elevated oxygen metabolism during 
hyperthermia in response to an increased rate of enzymatic reactions [122]. This finding can 
potentially elucidate another possible mechanism for cell death induced by hyperthermia. When 
normal cells encounter such an increased metabolism, increased blood flow provides more 
nutrients. By contrast, cancer cells could be damaged owing to inadequate blood circulation. 
Therefore, hyperthermia may kill cancer cells by both protein denaturation and cell starvation 
due to heating.  
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Figure	21.	mPAM	measurement	of	hemodynamic	responses	to	a	hyperthermic	challenge	(red	bars).	Relative	
changes	 of	 (a)	 the	 skin	 temperature,	 (b)	 vessel	 diameter,	 (c)	 total	 hemoglobin	 concentration,	 (d)	 oxygen	
saturation	(sO2),	(e)	blood	flow	speed,	and	(f)	oxygen	extraction	fraction	(OEF)	and	metabolic	rate	of	oxygen	
(MRO2).	Statistics:	paired	Student’s	t‐test.	*	p	<	0.05,	**	p	<	0.01,	n	=	3.		Data	are	presented	as	means	±	s.e.m.	
The	baseline	values	are	(a)	temperature:	31.0	±	0.4	ºC,	(b)	vessel	diameters:	92.5	±	10.5	µm	(vein)	and	47.5	±	
8.5	µm	(vein),	(c)	CHb:	146.3	±	18.1	g/l	(vein)	and	148.5	±	14.0	g/l	(artery),	(d)	sO2:	0.70	±	0.08	(vein)	and	0.94	
±	0.04	(artery),	(e)	flow	speeds:	1.3	±	0.4	mm/s	(vein)	and	5.1±	0.8	mm/s	(artery),	(f)	0.26	±	0.13	(OEF)	and	
0.30	±	0.09	ml/100	g/min	(MRO2).	
Change	in	MRO2	induced	by	local	cryotherapy	
Cryotherapy has been found effective for treating cancer and other diseases by forming ice 
crystals inside cells [123, 124]. Here, we applied liquid nitrogen to the mouse ear surface for 10 
seconds via a 1 mm diameter cryo-probe, and monitored the hemodynamics of the treated area 
(Figs. 22a-b). An untreated neighboring area of the same ear was also monitored as a control. 
Right after the treatment, a global reflective vasodilatation was observed on both the treated and 
control areas, which was accompanied by an increase in blood flow and a decrease in OEF. 
While the MRO2 of the control area remained unchanged statistically, the MRO2 of the treated 
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area decreased by 56% due to the induced cell death. Therefore, mPAM can be used to evaluate 
the efficacy of cryotherapy.  
 
Figure	 22.	mPAM	monitoring	 of	 hemodynamic	 responses	 after	 cryotherapy.	 (a)	mPAM	vasculature	 images	
acquired	in	different	phases	before	and	after	the	application	of	liquid	nitrogen.	The	treated	area	is	indicated	
by	cyan	dashed	circles.	Scale	bar:	500	µm.	(b)	mPAM	images	of	oxygen	saturation	(sO2)	in	the	artery‐vein	pair	
[cyan	dashed	box	in	(a)]	that	supports	the	treated	area.	Scale	bar:	125	µm.	
Within one month after the treatment, while all the parameters of the control area monotonically 
recovered to the baseline, the physiological progress of the treated area occurred in phases (Figs. 
23a-c). Within three days following the reflective vasodilatation, blood flow and OEF trended 
toward the baseline, but MRO2 remained at a low level due to cell necrosis. Starting from day 5, 
inflammation was clearly observed, which was triggered by the immune system and was helpful 
for both dead cell clearance and new cell growth. Although the OEF continued to decrease due to 
the increased flow speed [101], the MRO2 of the treated area eventually returned to the baseline, 
reflecting improved tissue viability. One month later, the inflammation nearly ended, and all the 
parameters had recovered almost to the baseline.  
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Figure	23.	mPAM	quantification	of	blood	 flow	 rate	 (a),	 oxygen	extraction	 fraction	 (OEF)	 (b)	 and	metabolic	
rate	of	oxygen	(MRO2)	(c)	within	30	days	after	the	treatment.	A	neighboring	area	close	to	the	treated	region	
was	monitored	as	a	control.	Statistics:	paired	Student’s	t‐test.	*	p	<	0.05,	**	p	<	0.01,	***	p	<	0.001,	n	=	4.		Data	
are	 presented	 as	means	 ±	 s.e.m.	 Baseline	 flow	 rates:	 0.72	 ±	 0.12	 µl/min	 (treated)	 and	 0.44	 ±	 0.15	 µl/min	
(control);	baseline	OEF:	0.35	±	0.04	(treated)	and	0.31	±	0.05	(control);	baseline	MRO2:	0.30	±	0.06	ml/100	
g/min	(treated)	and	0.25	±	0.07	ml/100	g/min	(control).	BL:	baseline.	
This study shows that each physiological phase after cryotherapy imparts its signature on the 
local MRO2. The common belief is that inflammation triggered by the immune response further 
helps kill tumor cells [125]. However, our results show that the increased blood flow rate during 
inflammation may assist the survival of residual tumor cells by providing more nutrients and thus 
recovering the MRO2 level.  
Early	cancer	detection	by	measuring	tumor‐induced	change	in	MRO2	
The third demonstration of mPAM is early cancer detection by measuring MRO2. The 
hemodynamics of the mouse ear were longitudinally monitored after the injection of B16 
melanoma cells (Fig. 24a). On day 7, vessel dilation appeared around the tumor site as shown in 
Fig. 24b and Fig. 25b. The volumetric blood flow rate increased by 1.5 fold (Fig. 24c and Fig. 
25e). These changes are important to ensure the supply of oxygen and nutrients to the rapidly 
growing tumor, and to provide routes for tumor cell metastasis [126]. The overall OEF of the 
tumor region decreased by 43% (Fig. 24c and Fig. 25f) due to the increased blood flow [101].  
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Figure	 24.	 	mPAM	 detection	 of	 early‐stage	melanoma	 by	measuring	metabolic	 rate	 of	 oxygen	 (MRO2).	 (a)	
White‐light	 photographs	 of	 a	 representative	 mouse	 ear	 before	 (day	 0),	 3	 days	 and	 7	 days	 after	 the	
xenotransplantation	of	B16	melanoma	tumor	cells.	Scale	bar:	1	mm.	(b)	mPAM	images	of	 the	 tumor	region	
[dashed	boxes	in	(a)]	at	584	nm.	z	is	coded	by	colors:	blue	(superficial)	to	red	(deep).	Scale	bar:	125	µm.	(c)	
mPAM	quantification	of	blood	flow	rate,	oxygen	extraction	fraction	(OEF)	and	metabolic	rate	of	oxygen	(MRO2)	
before	 (day	0),	 3	days	 and	7	days	 after	 the	 tumor	 xenotransplantation,	 normalized	by	 the	 values	 of	 day	 0	
(flow	rate:	1.77	±	0.50	µl/min;	OEF:	0.31	±	0.04;	MRO2:	0.38	±	0.03	ml/100	g/min).	Statistics:	paired	Student’s	
t‐test.	 **	p	<	 0.01,	 ***	p	<	 0.001,	n	 =	 5.	 	 Data	 are	 presented	 as	means	 ±	 s.e.m.	MT:	melanoma	 tumor;	 VD:	
vasodilatation.	
	
The vasculature and melanoma were differentiated according to their different absorption spectra 
using dual-wavelength excitation at 584 nm and 605 nm, and thus the tumor volume could be 
estimated (Fig. 26).  
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Figure	25.		mPAM	measurements	in	absolute	units	of	(a)	ear	weight,	(b)	vessel	diameter,	(c)	total	hemoglobin	
concentration,	 (d)	 oxygen	 saturation	 of	 hemoglobin	 (sO2),	 (e)	 volumetric	 blood	 flow	 rate,	 (f)	 oxygen	
extraction	fraction	(OEF),	(g)	rate	of	O2	consumption	in	µl/min,	and	(h)	metabolic	rate	of	oxygen	(MRO2)	in	
ml/100	g/min	up	to	21	days	after	tumor	inoculation.	Statistics:	paired	Student’s	t‐test.	*	p	<	0.05,	**	p	<	0.01,	
***	p	<	0.001,	n	=	3.		Data	are	presented	as	means	±	s.e.m.		
The hypermetabolism of melanoma was reflected by 36% increase in MRO2 (Fig. 24c), which 
proves the early cancer detection capability of mPAM. The presence of the melanoma was 
confirmed by histology (Fig. 27). However, the melanoma was hyperoxic instead of hypoxic in 
the early stage (Fig. 25d). On day 14, MRO2 dropped to the baseline level and continued to 
decrease (Fig. 25h), even though the total oxygen consumption rate increased steadily (Fig. 25g). 
There are two possible reasons for the final decline in MRO2. On one hand, a tumor changes to 
anaerobic respiration instead of aerobic respiration when it grows too quickly to get sufficient 
oxygen [92]; on the other hand, when the tumor grows too large, the tumor core dies due to a 
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decrease in available nutrients (necrosis). The necrotic tumor core does not consume oxygen but 
increases tumor weight (Fig. 25a), which decreases the MRO2 [127].   
 
Figure	 26.	 	 mPAM	 differentiation	 of	 blood	 vessels	 and	 melanoma.	 (a)	 White‐light	 photographs	 of	 a	
representative	mouse	ear	before	and	3	days	after	the	xenotransplantation	of	B16	melanoma	cells.	Scale	bar:	1	
mm.	 (b)	 Composite	 mPAM	 images	 of	 blood	 vessels	 (in	 red)	 and	 melanoma	 (in	 brown).	 The	 two	 are	
differentiated	 by	 using	 dual‐wavelength	 excitation	 at	 584	 nm	 and	 605	 nm.	 CHb:	 total	 hemoglobin	
concentration.	CM:	melanin	concentration.	Scale	bar:	250	µm.	MT:	melanoma	tumor.					
Besides melanoma, we also studied U87 human glioblastoma (Fig. 28a), which is more 
transparent; thus, its intratumoral vasculature can be better visualized. On day 7, angiogenesis 
was observed within the tumor region (Fig. 28b), and the sO2 of the draining vein was found to 
be increased, indirectly indicating early-stage tumor hyperoxia (Fig. 28c). The presence of the 
glioblastoma was confirmed by histology (Fig. 29). While the increase in blood supply for the 
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glioblastoma was comparable with that for the melanoma, the OEF showed a decrease by 24% 
instead of 43% (Fig. 28d). We observed a 100% increase in MRO2 instead of 36% for the 
melanoma, which indicated a stronger hypermetabolism at the early stage of glioblastoma. 
However, characteristic of early-stage cancer [128] , such hypermetabolism did not lead to tumor 
hypoxia. In fact, the sO2 in the intratumoral vasculature was even higher than that of the 
surrounding normal tissue, directly indicating early-stage tumor hyperoxia (Fig. 28e and Fig. 30). 
The increase in sO2 actually caused the decrease in OEF in the tumor. This observation suggests 
that hypoxia-based diagnosis may not apply to early-stage cancer [129].  
	
 
Figure	 27.	 Histological	 validation	 of	 melanoma	 detection.	 (a)	mPAM	 image	 of	 a	mouse	 ear	 bearing	 a	 B16	
melanoma	tumor	acquired	on	day	7.	z	is	coded	by	colors:	blue	(superficial)	to	red	(deep).	Scale	bar:	300	μm.	
(b)	 Images	of	H&E	stained	tissue	slices	cut	approximately	across	 the	 tumor	area	(top)	and	non‐tumor	area	
(bottom).	Scale	bar:	150	μm.	MT:	melanoma	tumor.	
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Figure	28.	mPAM	detection	of	early‐stage	glioblastoma	by	measuring	metabolic	 rate	of	oxygen	(MRO2).	 (a)	
White‐light	 photographs	 of	 a	 representative	 mouse	 ear	 before	 (day	 0)	 and	 7	 days	 after	 the	
xenotransplantation	of	U87	glioblastoma	tumor	cells.	Scale	bar:	2	mm.	(b)	mPAM	images	of	microvasculature	
in	 the	 tumor	region	 [dashed	boxes	 in	(a)]	at	584	nm.	z	 is	 coded	by	colors:	blue	 (superficial)	 to	red	(deep).	
Scale	bar:	250	µm.	(c)	mPAM	images	of	oxygen	saturation	(sO2)	in	the	artery‐vein	pair	[double	arrows	in	(b)]	
that	supports	the	tumor	region	acquired	on	day	0	and	day	7.	Scale	bar:	100	µm.	(d)	mPAM	quantification	of	
volumetric	 blood	 flow	 rate,	 oxygen	 extraction	 fraction	 (OEF)	 and	 MRO2	 7	 days	 after	 the	 tumor	
xenotransplantation,	normalized	by	the	values	of	day	0	(flow	rate:	1.03	±	0.41	µl/min;	OEF:	0.27	±	0.03;	MRO2:	
0.31	 ±	 0.09	 ml/100	 g/min).	 (e)	 Comparison	 of	 the	 averaged	 sO2	 values	 in	 the	 intra‐	 and	 extra‐tumoral	
vasculatures.	Statistics:	paired	Student’s	t‐test.	*	p	<	0.05,	**	p	<	0.01,	n	=	5.	 	Data	are	presented	as	means	±	
s.e.m.	GT:	glioblastoma	tumor.	 	
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Figure	29.		Histological	validation	of	glioblastoma	detection.	(a)	mPAM	image	of	a	mouse	ear	bearing	a	U87	
glioblastoma	tumor	acquired	on	day	7.	z	is	coded	by	colors:	blue	(superficial)	to	red	(deep).	Scale	bar:	250	μm.	
(b)	 Images	of	H&E	stained	tissue	slices	cut	approximately	across	the	 tumor	area	(left)	and	non‐tumor	area	
(right).	Scale	bar:	150	μm.	GT:	glioblastoma	tumor.	
3.4.3.	Conclusions	and	discussion	
The observations presented here demonstrate the power of mPAM as the only noninvasive label-
free imaging modality that can measure all the parameters required for the quantification of 
MRO2 in absolute units. Whereas MRO2 is the ultimate measure of oxygen metabolism, OEF and 
sO2 can be misleading partial measures. Unlike commonly believed, a decrease in OEF or an 
increase in sO2 does not necessarily indicate a decrease in MRO2. Strikingly, we found early-
stage cancer to be hyperoxic instead of hypoxic despite the hypermetabolism.  
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Figure	30.	 	 Label‐free	mPAM	of	hypermetabolism	and	hyperoxia	of	early	stage	 cancer.	 (a)	Photograph	of	a	
mouse	ear	bearing	a	xenographed	glioblastoma	on	Day	7.	Scale	bar:	2	mm.	(b)	mPAM	image	of	the	vasculature	
of	 the	mouse	 ear.	The	depth	 is	 color	 coded:	 blue	 (superficial)	 to	 red	 (deep).	 Scale	bar:	200	μm.	 (c)	mPAM	
image	of	the	sO2	of	the	tumor	region	in	(b).	It	is	clearly	shown	that	the	tumor	region	was	hyperoxic.	Scale	bar:	
200	μm.	
mPAM can non-invasively measure anatomical, functional, and fluid-dynamic information at the 
resolution of small vessels, making it possible for MRO2 quantification in microenvironments. 
MRO2-based early cancer detection and evaluation of its treatment are highly desirable. mPAM 
has also various other prospective applications related to MRO2. First, its high spatial resolution 
is essential for micro-hemodynamic studies, such as monitoring of local hemorrhage caused by 
mini-strokes. Second, its high sensitivity is critical for studies concerning small metabolic 
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changes, such as monitoring of neuro-vascular coupling in response to physiological challenges. 
Third, its potentially real-time imaging through fast optical scanning or ultrasonic-array detection 
is important for studies involving short transition times between physiological states, e.g., 
monitoring of epileptic seizures. Finally, its high spatial scalability enables us to correlate 
microscopic and macroscopic studies—e.g., monitoring of local neuron firing and overall brain 
activity—based on the same contrast. Overall, mPAM has strong potential for the study of 
metabolism in cancer and other metabolic diseases.   
4.	Improvements	in	photoacoustic	microscopy	
While AR-PAM has achieved so far tens of micrometers resolution with a penetration depth up 
to 3 mm in tissue [33], OR-PAM focuses on superficial imaging (up to ~1 mm in tissue) with at 
least capillary level resolution [7]. Recently, the imaging performance of OR-PAM has been 
significantly improved in terms of spatial resolution and imaging speed. By using a water-
immersion optical objective with a 1.23 numerical aperture (NA), a 220 nm lateral resolution at 
532 nm wavelength has been achieved [130]. Meanwhile, by using a fast voice-coil scanner, the 
sectional imaging speed of OR-PAM has been pushed to 40 Hz over a 1 mm scanning range 
[131]. To further expand the coverage of OR-PAM and push its commercialization, numerous 
efforts have been invested to improve its performances. Here, we are going to describe two 
aspects of the improvements of OR-PAM, including extending its imaging depth by double 
illumination and speeding up its imaging speed by using a fast scanning MEMS mirror. 
4.1.	Double	illumination	photoacoustic	microscopy	
So far, the penetration depth of OR-PAM is still restricted to one transport mean free path due to 
the strong optical scattering in tissue. Moreover, the strong absorption of hemoglobin in the 
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visible spectral range further reduces the 1/e penetration depth to less than 50 m in blood 
vessels, which may cause shallower vessels to shadow deeper vessels. This penetration limitation 
applies to both reflection-mode and transmission-mode OR-PAM. Only a layer of tissue on the 
optical illumination can be imaged [32, 36, 130, 132]. By illuminating light from both the top 
and bottom sides of the sample, we have developed a double-illumination PAM (DI-PAM) to 
improve the penetration depth to ~2 mm in thin biological tissue. At the same time, the optical 
focal zone is expanded to ~260 µm.  
4.1.1.	Methods	
In DI-PAM (Figure 1), a Nd:YVO4 laser (Elforlight, SPOT) generates 1.5 ns pulses at a 532 nm 
wavelength. The pulses are reshaped by an iris (ID25SS, Thorlabs) and attenuated by a neutral 
density filter (NDC-50C-2M, Thorlabs). The attenuated beam is then split into two sub-beams 
(top and bottom) by a 50/50 beam splitter (BSW04, Thorlabs). The top beam is focused by a 
condenser lens (LA1131, Thorlabs) before passing through a 50 m pinhole (P50C, Thorlabs) 
for further spatial filtering. The filtered beam is then focused by an optical objective (AC127-
050-A, Thorlabs. NA: 0.1 in air) into the sample from the top. A beam combiner composed of a 
thin layer of silicone oil sandwiched by a right-angle prism (NT32-545, EdmundOptics) and a 
rhomboid prism (NT49-419, EdmundOptics) provides acoustic-optical coaxial alignment. The 
resultant photoacoustic waves are detected by an ultrasonic transducer (V214-BB-RM, Olympus-
NDT) with a central frequency of 50 MHz. An acoustic lens with an NA of 0.5 is ground into the 
bottom of the rhomboid prism to provide an acoustic focal diameter of 30 μm. An optical 
correction lens is attached to the top of the beam combiner to correct the aberration. The acoustic 
lens is submerged in a water-tank for ultrasound coupling. The bottom beam duplicates the same 
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path as the top beam, except that it is directly focused into the sample from the bottom without 
going through the beam combiner and water tank.  
As shown in the inset of Fig. 31, by carefully adjusting the positions of two objectives, we 
achieved a co-axial configuration of the two optical foci and the acoustic focus. To best expand 
the optical focal zone, the top and bottom optical foci are both approximately one Rayleigh range 
apart from the acoustic focus. Volumetric imaging is acquired by two-dimensional raster 
scanning of the sample. While the lateral resolution is defined by the optical focus, the depth 
resolution is determined by the temporal resolution of the acoustic detection. An eyepiece is 
added to the bottom beam path to view the imaging region through the reverse path of the 
illumination. A photodiode is also added to monitor the fluctuations of the laser pulse intensity.  
 
Figure 31. . Schematic of DI-PAM. d1,2; Rayleigh range. ND, neutral density filter; BS, beam-splitter; ConL, 
condenser lens; PH, pinhole; M, mirror; OL, objective lens; CorL, correction lens; RAP, right-angle prism; SOL, 
silicone oil layer; RhP, rhomboid prism; UT, ultrasonic transducer; WT, water tank; SH, sample holder; MS, 
motor scanner; EP, eyepiece; PD, photodiode. 
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4.1.2.	Results	
Phantom	study	
To measure the lateral resolution of the DI-PAM system, a sharp ink edge was imaged in water 
at varied depths while the optical focus was fixed. From the edge spread function, the full width 
half maximum of the line spread function was computed to determine the lateral resolution. As a 
comparison, the lateral resolution under either top or bottom illumination was also quantified 
using the same protocol. The measured results were fitted using the theoretical model for a 
Gaussian beam ݓሺݖሻ ൌ ටݓ଴ଶ ൅ ሾఒሺ௭ି௭బሻగ௪బ ሿଶ, where ݓሺݖሻ is the lateral resolution at depth ݖ, ݓ଴ is 
the focal diameter, ߣ is the wavelength and ݖ଴ is the focal depth. While ߣ is known, ݓ଴ and ݖ଴ 
are the unknown parameters to fit for. As shown in Fig. 32a, the top illumination gives a focal 
diameter of 2.3 µm with a focal zone of 100 µm. Here, focal zone is defined as the range of 
depths over which the system maintains a lateral resolution no worse than √2ݓ଴. Similarly, the 
bottom illumination gives a focal diameter of 2.9 µm, with a focal zone of 170 µm. The two foci 
are 160 µm apart. The top illumination has a tighter focusing due to the addition of the correction 
lens which gives an effective NA of 0.133 in water, while the bottom illumination has an NA of 
0.1 in air. As can be seen in Fig. 32b, under double illumination, the lateral resolution has a ‘W’ 
shape distribution along the depth, which is determined by the overall light intensity of the two 
beams. The two valleys of the ‘W’ distribution are 2.3 µm and 2.9 µm in lateral resolution, 
which equal to the top and bottom focal diameters, respectively. The effective focal zone is 
expanded to 260 µm, which is the sum of the focal zones of the two valleys (100 µm and 160 µm, 
respectively). Thus, by increasing the focal zone by 160 µm over the top illumination or 90 µm 
over the bottom illumination, DI-PAM maintains the lateral resolution over a longer depth range.  
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Figure	 32.	 Lateral resolution as a function of the axial position relative to the starting depth of data-
acquisition, under top, bottom and double illumination illuminations, respectively. Solid curves: theoretical 
fitting. 
 
Figure	 33.	 Penetration	 depth	 of	 double‐illumination	 PAM.	 (a)	Side-view DI-PAM images of the human hair 
inside the chicken tissue under three illuminations. Scale bar: 200 µm. (b) Volumetric rendering of the human 
hair imaged by DI-PAM.	
To measure the penetration depth of the DI-PAM system, a black human hair was obliquely 
embedded in a 2-mm-thick piece of fresh chicken breast tissue. The two ends of the hair tightly 
pressed against the top and bottom surfaces of the tissue, and served as landmarks of the tissue 
boundaries. The top and bottom illuminations both had a pulse energy of 80 nJ. As shown in Fig. 
33a, while either single illumination can image only the top (1.16 mm) or bottom (1.25 mm) part 
of the hair, DI-PAM can clearly image the whole hair Fig. 33b, demonstrating a penetration 
depth of at least ~2 mm in biological tissue. 
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Animal	study		
The improved system performance enables DI-PAM to image deeper vasculature while 
maintaining capillary level lateral resolution. The mouse ear was chosen for a first demonstration. 
The ear of a 12-week-old nude mouse (Hsd:Athymic Nude-FoxnlNU, Harlan) is composed of a 
layer of auricular cartilage sandwiched by two layers of skin tissue (Fig. 34d). The ear of our 
experimental mouse became much thicker seven days after the injection of ~106 U87 
glioblastoma cells (Fig. 34c). A 10×15 mm2 area including the tumor region was sequentially 
imaged under top, bottom and double illuminations. In Fig. 34a, the depth-encoded maximum 
amplitude projection (MAP) images show that only the top layer vessels (shown in green) or 
bottom layer vessels (shown in red) can be well imaged under top or bottom illumination, 
respectively. Optical shadowing is the key reason. Although some big vessels from the other 
layer are discernable, they are very much blurred due to the degraded lateral resolution. In 
contrast, DI-PAM can clearly image both layers of vasculature without shadowing or blurring. 
The side-view MAP images in Fig. 34b further demonstrate the improvements of DI-PAM in 
penetration depth and focal zone, imaging through the whole ear with a thickness more than 1 
mm.  
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Figure 34. DI-PAM of mouse ear in vivo. (a) Top-view depth-encoded DI-PAM images of the right ear of a nude 
mouse bearing a U87 glioblastoma tumor, under top (TI), bottom (BI) and double (DI) illuminations, 
respectively. z is coded from green (superficial) to red (deep). Scale bar: 500 μm. (b) Side-view DI-PAM images 
under three illuminations. CHb, total hemoglobin concentration. Scale bar: 500 μm. (c) Photograph of the 
mouse ear. The imaged area is indicated by the blue dashed box. Scale bar: 2 mm. (d) Histology image of H&E 
stained tissue slice across the mouse ear. AC; auricular cartilage. Arrowheads; blood vessels. Scale bar: 100 
μm.  
	
In a second demonstration of DI-PAM, we imaged the vascular network surrounding the small 
intestine of a living black mouse (C57BL/6Hsd, Harlan), which is of interest in embryonic 
development and sepsis studies [133, 134]. After surgical exposure, part of the small intestine 
was gently pulled out and placed on the sample holder for DI-PAM imaging. The high vessel 
density on one side of the intestine would prevent imaging the other side by single-illumination 
PAM systems (Fig. 35e-f). In contrast, DI-PAM can obtain complete cross-sectional images of 
the intestine that is close to 2 mm in diameter (Fig. 35a-b). The depth-encoded MAP image 
shows a dense mesenteric vascular network, where the vessels from the top side were colored in 
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green and those from bottom side in red (Fig. 35a). The side-view MAP image of the section 
indicated by the dashed box in Fig. 35a appears to be a closed loop (Fig. 35b). The villi on the 
lumen of the intestine are also clearly resolved (Fig. 35c).  
 
Figure 35. DI-PAM of the small intestine of a C57BL/6 mouse in vivo. (a) Top-view depth-encoded DI-PAM 
image of the small intestine under double illumination. Scale bar: 500 μm. (b) Side-view DI-PAM image of the 
region indicated by the dashed box in (a). CHb, total hemoglobin concentration. Scale bar: 250 μm. (c) Close-up 
of the small region indicated by the dashed box in (b). The intestinal villi are indicated by the arrowheads. 
Scale bar: 100 μm. (d) Volumetric rendering of the small intestine imaged by DI-PAM. (e) Photograph of the 
small intestine after surgical exposure. Scale bar: 1 mm. (f) Histology image of H&E stained cross-section of 
the small intestine. Arrowheads; blood vessels. Scale bar: 200 μm. 
4.1.3.	Conclusions	and	discussion	
In conclusion, we have developed double-illumination PAM, which offers improved penetration 
depth and expanded focal zone. Compared with traditional reflection or transmission mode OR-
PAM, the penetration depth has been improved to at least 2 mm in biological tissue. In addition, 
the focal zone has been improved to 260 m, with a lateral resolution no worse than 4 m. Deep 
microscopy of microvascular anatomy in a mouse ear and small intestine was performed. 
Although not demonstrated here, DI-PAM is intrinsically ready for label-free measurements of 
oxygen saturation, blood flow, and oxygen metabolism.  
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Simply doubling the incident light intensity for single illumination OR-PAM can also increase 
the penetration depth. However, the resultant improvement is not equivalent to that provided by 
DI-PAM. First, doubling incident light will not result in doubling of the penetration depth, since 
the attenuation of light by tissue is exponential rather than linear. Second, in DI-PAM, the light 
intensity on the tissue surface was 22 mJ/cm2 for both top and bottom illuminations, which is 
still close to the American National Standards Institute (ANSI) safety limit (20 mJ/cm2 in the 
visible spectral region). However, simply doubling the light intensity for single illumination (44 
mJ/cm2) will beak the ANSI limit and thus increase the risk of damaging tissue.        
The focal zone of single illumination OR-PAM can also be expanded by depth scanning and 
stacking the data sets together. However, this is not equivalent to the improvement due to DI-
PAM. First, strong tissue scattering would degrade the lateral resolution as the focal position 
deepens. Second, the imaging time would be increased by depth scanning. In contrast, DI-PAM 
expands the focal zone without sacrificing lateral resolution and imaging speed. 
4.2.	MEMS	scanning	mirror	based	fast	scanning	photoacoustic	microscopy	
As all living biological systems are dynamic, it is also important to develop fast-scanning OR-
PAM systems. Several scanning mechanisms have been reported to push the imaging speed of 
OR-PAM. The first type is to optically scan the laser beam within the focal spot of the ultrasonic 
transducer [135, 136]. This mechanism, however, suffers from a limited scanning range of ~100 
m and inhomogeneous detection sensitivity within the field of view (FOV) [135, 136]. The 
second method is to optically scan the laser beam within the detection area of an unfocused 
ultrasonic transducer [132, 135]. This method increases the scanning range to a few millimeters, 
while reducing the overall detection sensitivity by more than 40 dB. The third form is to 
mechanically scan by mounting the whole imaging head on a voice-coil scanner [137]. This 
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design can maintain the confocal alignment and increase the scanning range to a few millimeters, 
but over which the scanning speed can reach only ~40 Hz, limited by the mass of the imaging 
head. Different fast-scanning methods for PAM imaging are summarized in Table 1. 
Table	1:	Comparison	of	fast‐scanning	methods	
Scanning methods  B‐scan rate 
(Hz/mm) 
Scanning range 
(mm)  SNR 
a   Transducer 
focusing 
Detection 
homogeneity b  Ref 
Mechanical scanning  1  >10  +++  Spherical  +++  [32] 
Multifocal scanning 
(transducer array)  4  ~5  ++  Cylindrical  ++  [138] 
Hybrid scanning  24  ~4  ++  Cylindrical  ++  [139] 
Voice‐coil scanning  40  >5  +++  Spherical  +++  [140] 
2D optical scanning 
(unfocused transducer)  100  ~6  +  Unfocused  +++  [132] 
2D optical scanning 
(focused transducer)  180  <0.1  ++  Spherical  +  [135] 
a More plus signs indicate better SNR. 
b More plus signs indicate better homogeneity of the acoustic detection over the scanning range.  
Here, we present a wide-field fast-scanning OR-PAM by using a lab-made water-immersible 
MEMS (i.e., microelectromechanical system) scanning mirror (MEMS-OR-PAM). A cross-
sectional (B-scan) imaging rate of 400 Hz over a 3 mm range has been achieved. By scanning 
both the excitation laser beam and resultant acoustic beam, MEMS-OR-PAM maintains confocal 
alignment and high detection sensitivity over a large FOV.  
4.2.1.	Methods	
Fig. 36 is a schematic of the MEMS-OR-PAM. The light source is an Nd:YVO4 laser (AOT-
YVO-100Q, AOT Inc.,) which generates 2 ns pulses at 532 nm with a repetition rate of 100 kHz. 
The laser beam is focused by a condenser lens (LA1131, Thorlabs) then spatially filtered by a 
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50-μm-diameter pinhole (P50C, Thorlabs). The filtered beam is focused by an optical objective 
lens (AC127-050-A, Thorlabs. NA: 0.1 in air). A beam combiner composed of an aluminum-
coated prism (NT32-331, Edmund) and an uncoated prism (NT32-330, Edmund) provides 
acoustic-optical coaxial alignment. The thin aluminum coating provides optical reflection but 
acoustic transmission. The focused laser beam is directed towards the sample surface by the 
aluminum coating of the combiner and a MEMS scanning mirror plate. An optical correction 
lens attached to the top surface of the combiner corrects the aberration due to the prism. The 
resultant photoacoustic waves are reflected by the MEMS scanning mirror and detected by an 
ultrasonic transducer (V214-BB-RM, Olympus-NDT), which has a central frequency of 50 MHz 
and a -6 dB bandwidth of 66%. An acoustic lens with an NA of 0.25 (NT45-010, Edmund) is 
attached to the right surface of the combiner and provides an acoustic focal spot size of ~80 μm 
in water. The acoustic NA of this system is chosen to be ~50% less than that of previously 
reported OR-PAM systems because fitting the MEMS scanning mirror requires a longer working 
distance. The whole imaging head is submerged in a water tank for ultrasound coupling. 
Volumetric imaging is provided by fast angular scanning of the MEMS scanning mirror along 
the x-axis and step motor scanning of the sample along the y-axis.  
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Figure	 36.	 Schematic	 of	 MEMS‐OR‐PAM.	 CL,	 condenser	 lens;	 AC,	 aluminum	 coating;	 AL,	
acoustic	lens;	UT,	ultrasonic	transducer.	
As shown in Fig. 37, the MEMS mirror plate is made of silicon with a gold coating, thus 
provides a good condition for reflecting both the optical and acoustic beams. The mirror plate is 
supported by two hinges made of high-strength flexible polymer materials, which can resist 
surface tension forces in liquids. To actuate the mirror, high efficient electromagnetic force is 
generated by a compact inductor coil and a pair of high-strength rare-earth permanent magnets 
on the back of the mirror plate. A sinusoidal current applied to the inductor coil generates a 
magnetic field with alternating polarity and strength, which drives the mirror plate to oscillate 
around the hinges. By controlling the frequency and amplitude of the driving voltage, the 
scanning speed and range can be adjusted appropriately. 
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Figure	37.	MEMS‐scanning	mirror.	(a‐b)	Schematics	of	the	top	(a)	and	side	(b)	views	of	the	water‐immersible	
MEMS	scanning	mirror.	(c)	Photograph	of	a	fabricated	prototype	device.	The	silicon	mirror	plate	was	coated	
with	a	thin	gold	layer.	PF,	polymer	frame;	PM,	permanent	magnet;	AF,	actuation	force;	AH,	acrylic	holder.	
4.2.2.	Results	
Phantom	study	
To measure the lateral resolution of the MEMS-OR-PAM system, the edge of a sharp blade was 
imaged in water. From the edge spread function, the full width at half maximum of the line 
spread function is estimated to be 2.4 µm, which is close to the theoretical, diffraction-limited 
focal spot size of the laser beam (2.1 µm) (Fig. 38). The optical focal zone is about 154 µm, in 
which the lateral resolution is within 5 µm. The axial resolution was estimated to be ~40 μm 
based on the transducer bandwidth and the speed of sound in tissue. Both the lateral and the axial 
resolutions decrease with imaging depth due to increasing optical scattering and frequency-
dependent acoustic attenuation in tissue, respectively.  
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Figure	38.	Line	spread	function	used	to	measure	the	lateral	resolution	of	the	system	(red	circles,	the	averaged	
pixel	values;	blue	line,	the	Gaussian	fit).	
The maximum penetration depth of the MEMS-OR-PAM was experimentally quantified by 
obliquely inserting a 250-μm-diameter black needle into the leg of an anesthetized nude mouse. 
As shown in Fig. 39, after time-gain compensation for the optical and acoustic attenuation, the 
system can clearly image the needle down to 1.1 mm beneath the skin surface, which is 
comparable to other OR-PAM systems.[36, 137]  
 
Figure	39.	MEMS‐OR‐PAM	image	of	a	black	needle	inserted	obliquely	into	the	leg	of	a	living	mouse.	A	1.1	mm	
in	vivo	imaging	depth	was	achieved	with	time‐gain	compensation.	
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Different from the linear scanning of traditional OR-PAM systems [32, 36, 137], the angular 
scanning of MEMS-OR-PAM results in a curved focal plane with a radius of 7 mm. The 
maximum in-focus scanning range is ~3.0 mm along the x-axis. Since raw B-scan images are in 
the polar coordinates (Fig. 40a), we converted the data to Cartesian coordinates considering the 
scanning geometry and applying a 2D linear interpolation (Fig. 40b). For a uniform black-tape 
target, the averaged PA signal amplitude varies less than 5% along the x-axis (Fig. 40b). The 
result demonstrates that MEMS-OR-PAM maintains uniform detection sensitivity along the 
scanning direction, superior to other fast scanning methods where the confocality is 
compromised.  
 
Figure	40.	Scanning	trace	correction	of	MEMS‐OR‐PAM.	(a)	Raw	B‐scan	image	of	a	piece	of	flat	black‐tape	in	
polar	coordinates.	The	angular	scanning	of	the	MEMS	mirror	introduced	the	curvature	of	the	imaged	target	
surface.	φ,	scanning	angle	of	the	MEMS	mirror.	(b)	B‐scan	image	in	Cartesian	coordinates	converted	based	on	
the	scanning	geometry	and	2D	linear	interpolation.			
Animal	study	
Red blood cell (RBC) flow in a nude mouse ear was imaged in vivo by MEMS-OR-PAM to 
demonstrate its high-speed imaging capability. All experimental animal procedures were carried 
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out in conformity with the laboratory animal protocol approved by the Animal Studies 
Committee at Washington University in St. Louis. As shown in Fig. 41, a 2 × 5 mm2 area of the 
mouse ear was repeatedly scanned with a volumetric imaging speed of 0.8 Hz (a 2D B-scan rate 
of 400 Hz), which is about 400 times faster than the second-generation OR-PAM system and 20 
times faster than the most recent voice-coil based OR-PAM scanner for the same scanning range 
[36, 137]. The laser pulse energy on the skin surface was measured to be 100 nJ. Since 532 nm is 
close to the isosbestic wavelength, the PA signal amplitude reflects the total hemoglobin 
concentration regardless of the oxygenation of hemoglobin. The spatial resolution is sufficient 
for resolving the capillary beds (Fig. 41), and the imaging speed enables the mapping of the RBC 
movements in small vessels. The average signal to noise ratio (SNR) is 36.5 dB, which is about 6 
dB less than that of the second-generation OR-PAM system, due to the smaller NA of the 
employed acoustic lens [36]. Nevertheless, this SNR is adequate for single RBC imaging [36, 
137].  
 
Figure	41.	MEMS‐OR‐PAM	of	blood	flow	dynamics	of	the	vasculature	in	a	mouse	ear.	Capillaries	were	clearly	
resolved,	and	the	flow	dynamics	over	a	2	×	5	mm2	area	were	imaged	with	a	0.8	Hz	volumetric	frame	rate	and	
400	Hz	B‐scan	rate.	
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In addition to the RBC flow imaging based on endogenous contrast, intravascular transport of an 
exogenous contrast agent was also explored using the system. First, we imaged a 0.6 × 2 mm2 
area of a nude mouse ear as a control with laser pulse energy of 100 nJ (Fig. 42a). Then, we 
injected carbon particles with ~6 µm diameters (2.5% w/v, carbon glassy spherical powder, 
Sigma-Aldrich) into the blood stream of the nude mouse via its tail vein. A 0.3 × 1 mm2 area 
which contained a 40-µm-diameter vein was chosen as the region of interest (ROI) for dynamic 
imaging. The ROI was repeatedly imaged with a volumetric frame rate of 4 Hz. Lower pulse 
energy of 10 nJ was used to image only the particles, which are much more absorbing than 
hemoglobin. As shown in Fig. 42b, the average flow speed of the particles in the vein was much 
slower than the RBC flow [80]. This is likely due to the larger mass density of the particles (1.46 
g/cm3).    
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Figure	42.	MEMS‐OR‐PAM	of	flow	dynamics	of	carbon	particles.	(a)	MEMS‐OR‐PAM	image	of	a	mouse	ear	with	
a	pulse	energy	of	100	nJ,	where	the	blood	vessels	were	imaged.	(b)	After	the	injection	of	carbon	particles	via	
the	tail	vein,	a	smaller	region	indicated	by	the	dashed	box	in	(a)	was	monitored	with	a	4	Hz	volumetric	frame	
rate.	The	pulse	energy	was	reduced	to	10	nJ	to	image	only	the	particles.	The	dashed	lines	are	the	boundaries	
of	the	vessel	containing	the	flowing	particles.	A	representative	particle	is	indicated	by	the	arrows.	
4.2.3.	Conclusions	and	discussion	
In summary, we have developed MEMS-OR-PAM that can dramatically improve the imaging 
speed while maintaining the confocal alignment of the optical and acoustic beams over a wide 
FOV. Conserving the high spatial resolution and imaging sensitivity of traditional OR-PAM 
systems, we achieved a B-scan imaging speed of 400 Hz over a 3 mm scanning range, currently 
limited by the repetition rate of the employed laser system. The scanning range can be traded off 
for imaging speed. A laser system with higher repetition rate or an intensity-modulated 
continuous wave laser can further improve the imaging speed. By employing a dual-wavelength 
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laser source, MEMS-OR-PAM is intrinsically capable of label-free measurements of oxygen 
saturation and oxygen metabolism [39]. 
PAM can also improve its imaging speed through parallel acoustic detection by ultrasound 
transducer arrays. In a multi-focal OR-PAM system, twenty diffraction-limited focal spots are 
simultaneously excited, and the resultant PA signals are detected by a 48-element ultrasound 
linear array [138]. Limited by the 6:1 multiplexing in data acquisition, the imaging speed is 
eventually improved by three to four times, compared with that in conventional single-focus and 
single-detector OR-PAM. However, this method needs twentyfold more laser energy than 
conventional OR-PAM. Besides, because of the inverse reconstruction of PA images, 
reconstruction artifacts due to the limited detection aperture may degrade the image quality.   
Currently, it is the laser repetition rate that limits the imaging speed in PAM. Theoretically, real-
time (≥30 Hz) volumetric imaging over a 1 × 1 mm2 surface area needs a 5 MHz laser with a 
pulse energy of 100 nJ for OR-PAM, or a 50 kHz laser with a pulse energy of 100 J for AR-
PAM. To avoid interference between PA waves excited by consecutive pulses, it is the acoustic 
flight time that limits the ultimate imaging speed. For example, to image a sample with a 
thickness of 1 mm, the minimum time interval between consecutive pulses should be 0.67 µs, 
which corresponds to a maximum laser repetition rate of 1.5 MHz.  
5.	Biomedical	applications	of	multi‐contrast	photoacoustic	microscopy	
(tomography)	
By offering high-resolution images with unique optical contrast, PAM has so far been applied to 
numerous preclinical and human studies, including vascular biology [141-143], oncology [82, 
100, 144-149], neurology [74, 150-152], ophthalmology [132, 153-156], dermatology [157-161], 
gastroenterology [162-166], and cardiology [35, 167-169]. Here, we are going to introduce 
several representative applications. Although photoacoustic computed tomography (PACT) is 
not the major topic of this dissertation study, its imaging speed is typically faster than PAM due 
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to the parallel acoustic detection by transducer array. Dynamic metabolism of mouse brain was 
imaged by PACT in combination with PAM and fluorescence study.  
5.1.	 Immediate	 alterations	 in	 intestinal	 oxygen	 saturation	 and	 blood	 flow	
following	 massive	 small	 bowel	 resection	 as	 measured	 by	 photoacoustic	
microscopy	
Short gut syndrome is a condition of high morbidity and mortality within the pediatric population 
and results primarily from massive intestinal loss. After a massive small bowel resection (SBR) 
in both animal models and humans, a critical adaptation response occurs within the remnant 
bowel and is characterized by significant increases in villus height and crypt depth, resulting in 
increased absorptive mucosal surface area to compensate for the attenuated bowel length [170-
172]. Angiogenesis has long been recognized as important in states of cellular proliferation [173, 
174]. The contribution of villus angiogenesis to intestinal adaptation has recently been 
demonstrated. Proangiogenic growth factor supplementation has been shown to enhance 
intestinal mucosal growth [175], and inhibition of vascular endothelial growth factor has resulted 
in a decreased adaptive response after intestinal loss [176].  Previous study has established an 
increased villus capillary density on postoperative day 7 in mice that have undergone massive 
SBR [177]. This is preceded on postoperative day 3 by an increase in the gene expression of 
proangiogenic chemokine ligand 5 [178]. The exact stimulus for these proangiogenic changes as 
well as the acute alterations in intestinal hemodynamics following SBR are presently unknown.   
Previous ex vivo studies of intestinal blood flow at late time points after SBR are conflicting. 
Studies using intravascular injections of radioactive particles and measurement of radioactivity 
from harvested tissue as surrogate markers for blood flow have demonstrated increased blood 
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flow following SBR distal to the site of intestinal anastomosis as soon as twenty-four hours 
following resection, however, the duration of this hyperemic response has been variable [179-
181].  In addition, these studies did not measure other parameters of hemodynamics, including 
oxygen saturation of hemoglobin (sO2).  No prior studies have measured hemodynamic 
parameters within the remnant gut immediately after bowel resection using an in vivo, real time 
imaging system with endogenous contrast.  
To overcome the limitations of the imaging tools used in prior studies, we sought to determine 
the effect of SBR on intestinal hemodynamics using photoacoustic microscopy (PAM), a non-
invasive, label-free, high-resolution hybrid imaging modality. With the help of PAM, a better 
understanding of the acute hemodynamic changes following SBR may further elucidate a 
mechanism for villus angiogenesis and the pathogenesis of intestinal adaptation. 
5.1.1.	Materials	and	methods	 	
Experimental	design	
A protocol for this study was approved by the Washington University Animal Studies 
Committee (no 20090275) in accordance with the National Institute of Health laboratory animal 
care and use guidelines.  Mice underwent either 50% proximal SBR (n=7) or sham (enterotomy 
alone) (n=7) procedure as previously described [170]. Photoacoustic microscopy measurements 
of the terminal mesenteric arteriole and accompanying vein vessel diameter, blood flow, and 
oxygen saturation were obtained at 6 cm proximal to the ileal-cecal junction (ICJ) and at 12 cm 
proximal to the ICJ on the serosal surface of the intestine both prior to and immediately 
following the procedure.   
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Male mice (C57BL/6; Harlan Laboratories, Inc.; Indianapolis, IN) age 8 to 15 weeks were used 
in this study. Mice were kept on a 12-hour light-dark cycle and housed in a standard facility. The 
mice were given free access to standard rodent food pellets and water up until the time of the 
procedure.  
Operative	technique	
Mice underwent 50% proximal SBR or sham (enterotomy alone) as previously reported [170] 
with the exception that no reanastamosis was performed. Briefly, a midline laparotomy was 
made and the bowel was exposed for photoacoustic measurements. Mice that underwent SBR 
had transection of the bowel at 12 cm proximal to the ICJ and at 1 to 2 cm distal to the ligament 
of Treitz. The mesentery of the intervening bowel was ligated with a silk tie and the intervening 
bowel was removed.  In mice that underwent the sham procedure, the bowel was transected only 
at 12 cm proximal to the ICJ.   
Intestinal	sO2	and	blood	flow	measured	by	photoacoustic	microscopy	
During the experiment, mice were anesthetized with isoflurane (E-Z Anesthesia, Euthanex) and 
placed in a supine position on a heating pad (37 ºC).  A midline laparotomy was performed and 
the entirety of the small bowel was exposed, The terminal mesenteric artery and accompanying 
vein at a point approximately 6 cm and 12 cm proximal to the ICJ were identified. Baseline sO2 
was measured at both locations on a 1 × 4 mm2 area containing such vessel pairs at two optical 
wavelengths of 532 nm and 560 nm using a previous publish method [88]. Baseline blood flow 
speed measurement was then performed at both locations across the proximal end of the vessel in 
M-mode using a bandwidth broadening based method [80, 81].  The laser repetition rate was 10 
kHz, and 4000 A-lines were acquired at each position. The area of the bowel not being measured 
was kept moistened with a normal saline soaked gauze pad. The animal then underwent SBR or 
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sham procedure. Following the procedure, the same artery and vein pairs at 6 cm and 12 cm 
proximal to the ICJ were imaged with sO2 and blood flow measurements recorded. Following all 
measurements the animal was sacrificed via cervical dislocation.  
Statistical	analysis	
All the photoacoustic data processing was conducted using MATLAB (R2008a, MathWorks). 
Quantitative values are presented as mean ± SEM.  An unpaired Student's t-test was used for 
comparisons between all measurements.  A p value less than 0.05 was considered to be 
statistically significant. The Sigma Stat statistical package (SPSS, Chicago, IL) was used for all 
statistical analyses.  
5.1.2.	Results	
A total of 7 mice underwent the SBR procedure with post-SBR measurements and 7 mice 
underwent the sham procedure with post-sham measurements. The presented pre-operative data 
(n=7) represents that of the SBR group only as variability in the pre-operative measurements 
amongst all animals was minimal. Only data from the measurements recorded at 6 cm proximal 
to the ICJ is presented as this mid-remnant bowel location best represents the hemodynamic 
changes throughout the entire remnant small bowel.  In all cases the 6 cm measurement agreed 
with the trend from measurement at the 12 cm proximal to the ICJ location.  
Arterial	and	venous	oxygen	saturation	
Prior to SBR, arterial and venous oxygen saturations (%) were similar (0.98 ± 0.01 arterial pre vs 
0.98 ± 0.02 venous pre at 6 cm, p value: 0.70). Immediately following SBR, the arterial oxygen 
saturation decreased (0.98 ± 0.01 pre vs 0.84 ± 0.06 post-SBR at 6 cm, p value: <0.05).  This 
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trend towards decrease in arterial oxygen saturation was also observed following sham (0.98 ± 
0.01 pre vs. 0.95 ± 0.01 post-sham at 6 cm, p value: 0.06; Fig. 43a). 
 
Figure	43.	Oxygen	saturation	(sO2)	of	the	terminal	mesenteric	arteriole	(a)	and	accompanying	vein	(b)	pre‐
operatively,	 post‐sham	 (bowel	 transection	 alone),	 and	 post‐SBR	 at	 a	 location	 6	 cm	 from	 the	 ileal‐cecal	
junction.	 	Asterisk	 indicates	p	<	0.05	as	compared	to	pre‐op	(pre‐op	vs	sham	and	pre‐op	vs	SBR).	 	Number	
sign	indicates	p	<	0.05	sham	vs	SBR.			
Venous oxygen saturation dramatically decreased immediately following SBR (0.98 ± 0.02 pre 
vs 0.66 ± 0.05 post-SBR at 6 cm, p value: <0.001).  This decrease in venous oxygen saturation 
was also observed to a lesser degree following sham (0.98 ± 0.02 pre vs 0.86 ± 0.02 post-sham at 
6 cm, p value: < 0.001, Fig. 43b).The difference between arterial and venous oxygen saturation 
post-SBR and post-sham was statistically significant, with the venous oxygen saturation 
decreasing to a greater extent than the arterial (p value: <0.05). The pronounced difference in 
arterial and venous oxygen saturation pre-op and post-SBR are demonstrated in Fig. 44. 
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Figure	 44.	 Photoacoustic	microscopy	 images	 of	 intestinal	microvascular	 structure	 and	 arterial	 and	 venous	
oxygen	saturation	(sO2)	pre‐operatively	and	post‐SBR.			
Tissue	oxygen	extraction		
Tissue oxygen extraction fraction (OEF) is defined as  and represents 
the fraction of O2 molecules that cross the capillary wall. We found that OEF dramatically 
increased post-SBR (0.01 ± 0.01 pre vs 0.21 ± 0.04 post-SBR at 6 cm, p value: < 0.001). OEF 
also increased post-sham (0.01 +/- 0.01 pre vs 0.09 +/- 0.02 post-sham at 6 cm, p value: < 0.05); 
however, the increase in OEF post-SBR was significantly greater than post-sham (0.21 ± 0.04 
post-SBR vs 0.09 ± 0.02 post-sham, p value: < 0.05, Fig. 45). 
 2 2 2sO sO s/ Oartery vein artery
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Figure	 45.	 Tissue	 oxygen	 utilization	 pre‐operatively,	 post‐sham,	 and	 post‐SBR	 at	 a	 location	 6	 cm	 from	 the	
ileal‐cecal	junction	as	calculated	by	the	oxygen	extraction	fraction.	Asterisk	indicates	p	<	0.05	as	compared	to	
pre‐op	(pre‐op	vs	sham	and	pre‐op	vs	SBR).		Number	sign	indicates	p	<	0.05	sham	vs	SBR.			
Arterial	and	venous	blood	flow		
Following SBR, the arterial blood flow decreased (7.6 ± 1.5 mm/s arterial pre vs 2.6 ± 0.55 mm/s 
post-SBR at 6 cm, p value: < 0.05). No change in arterial blood flow was observed in the sham 
group (7.6 ± 1.5 mm/s arterial pre vs 7.7 ± 0.6 mm/s post-sham, p value: 0.93) (Fig. 46a). 
Venous blood flow also decreased following SBR (4.0 ± 0.7 mm/s venous pre vs 1.6 ± 0.5 mm/s 
venous post-SBR at 6 cm, p value: < 0.05).  No change in venous blood flow was observed in the 
sham group (4.0 ± 0.7 mm/s venous pre vs 4.0 ± 0.5 mm/s venous post-sham, p value: 0.98) (Fig. 
46b). 
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Figure	46.	Blood	flow	(mm/second)	of	the	terminal	mesenteric	arteriole	(a)	and	accompanying	vein	(b)	pre‐
operatively,	post‐sham,	and	post‐SBR	at	a	 location	6	cm	from	the	 ileal‐cecal	 junction.	Asterisk	 indicates	p	<	
0.05	as	compared	to	pre‐op	(pre‐op	vs	sham	and	pre‐op	vs	SBR).		Number	sign	indicates	p	<	0.05	sham	vs	SBR.	
5.1.3.	Conclusions	and	discussion	
SBR results in villus angiogenesis and intestinal adaptation [177]. While previous studies have 
attempted to measure changes in blood flow following SBR using ex vivo methodologies and 
surrogate markers of blood flow, this is the first study to examine the effects of intestinal 
resection on hemodynamics using an in vivo imaging modality.  
The present study demonstrates that PAM is a useful tool for measuring intestinal hemodynamics. 
The use of hemoglobin as endogenous contrast eliminates the potential disturbance to the 
intestinal system induced by exogenous contrast. High spatial resolution enables 
microenvironmental studies down to the level of the capillaries.  The spatial resolutions of PAM 
can also be scaled for deeper tissue imaging [8]. Real-time imaging ability provides for acute 
response monitoring. In addition, the minimum invasiveness of PAM enables longitudinal 
studies on the same animal.  
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The results of the present study demonstrate that at baseline, prior to intervention, arterial and 
venous sO2 of the terminal mesenteric artery and accompanying vein are similar.  This may 
indicate minimal to no tissue oxygen utilization of the supplied intestine. Previous ex vivo studies 
of intestinal sO2 using radioactive microspheres have demonstrated a significant difference 
between arterial and venous sO2 in both the fasting and the fed state of other animal models.  
Stevenson and Weiss record in rats a 93.7% fasted arterial sO2 in comparison to a 35.8% fasted 
venous sO2; fed arterial and venous sO2 were respectively similar.  Other studies have 
demonstrated increased tissue oxygen uptake in piglets following oral feeds.  In the present study, 
animals were not fasted prior to measurement, but given free access to standard rodent chow, 
making the timing of the animal’s last meal a variable factor. However, given the minimal 
variability in the pre-operative measurements of both blood flow and oxygen saturation, this 
appears to have had minimal effect.  While this contradicts previous ex vivo studies in other 
animal models, our in vivo results suggest either a high physiologic reserve in mice, and/or left-
to-right shunting within the intestinal wall even with a metabolically active state. 
Immediately following SBR, hemodynamic changes occur consistent with a reduced oxygen 
delivery. Venous sO2 drops dramatically post-SBR. A less dramatic decrease in venous sO2 also 
occurs post-sham, likely related to the metabolic effects of transection alone. It is unclear at this 
point in time the significance of the drop in arterial sO2 post-SBR and post-sham. However, the 
overall oxygen extraction fraction post-SBR increases significantly, representing increased tissue 
oxygen utilization within the remnant bowel. Further, both arterial and venous blood flow 
decreased post-SBR. Such decrease in blood flow was not seen post-sham and likely represents 
an immediate reaction to ligation of 50% of the small bowel mesentery and vasculature, and not 
85 
 
a reaction to the acute blood loss from the transected marginal artery of the intestine that occurs 
both post-SBR and post-sham from the associated enterotomy. 
Hypoxia is a well-recognized trigger of angiogenesis, resulting in the activation of hypoxia-
inducible factors (HIF), responsible for transcriptional activation of genes [182].  In states of 
intestinal mucosal inflammation, HIFs have been shown to have a protective role. In a study by 
Karhausen et al, transgenic intestinal epithelial overexpression of HIF-1 protected against 
trinitrobenzene sulfuric acid-induced colitis, while loss of epithelial HIF-1 resulted in increased 
colitis severity, weight loss, intestinal permeability, and mortality [183]. It is plausible that 
cellular changes in response to hypoxia post-SBR may act in a similar manner, having a pro-
angiogenic and protective role in the intestinal epithelium. 
Previous studies of hemodynamic alterations following SBR have demonstrated a hyperemic 
response to SBR [179-181], however the earliest time point studied in those experiments was 24 
hours after resection. In contrast, the data from this study represents changes of the intestinal 
microvasculature within the first hour post-SBR. It is unclear at this point in time the duration of 
the hypoxic changes that occur immediately after resection, but further investigation is underway 
to determine the changes in hemodynamics that occur as the bowel undergoes adaptation. Our 
laboratory’s previous work has demonstrated an increased villus capillary blood vessel density 
within the remnant bowel on post-operative day 7 [177]. Such new blood vessel growth may be 
supported by increased blood flow as adaptation occurs.  
Intestinal adaptation in response to massive SBR is a multifactorial process involving 
angiogenesis, cellular proliferation, and apoptosis. Through the use of photoacoustic microscopy, 
the immediate intestinal hemodynamic changes that occur after SBR, and resultant hypoxia, are 
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novel findings that provide possible mechanistic insight into the changes that occur within the 
remnant bowel within minutes of resection. The duration of intestinal hypoxia, cellular effects of 
such hypoxic changes, and impact on villus angiogenesis remain to be studied. A better 
understanding of hypoxia following SBR and the role of angiogenesis in intestinal adaptation 
may help in the development of future therapeutic treatments for patients with short gut 
syndrome. 
5.2.	Non‐invasive	photoacoustic	tomography	and	microscopy	of	mouse		brain	
metabolism	in	vivo	
In mammals, the brain coherently controls the overall action of the body [184]. Performing 
numerous computation-intensive tasks such as information processing, perception, motor control 
and learning, brain tissue consumes a large amount of energy in proportion to its volume [185]. 
For example, humans devote 20-25% of their metabolism to the brain, where the energy is 
mostly used for sustaining the electric charge (membrane potential) of neurons [185, 186]. In 
humans and many other species, the brain gets most of its energy from oxygen-dependent 
metabolism of glucose [185]. An abnormal metabolic rate of glucose and/or oxygen usually 
reflects a diseased status of brain, such as cancer or Alzheimer’s disease [187, 188]. In addition, 
physiologically active regions of the cerebral cortex consume more energy than inactive regions 
[189]. These phenomena have formed the basis for functional brain imaging methods, including 
positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) [190, 
191]. 
However, PET depends on the administration of radioactively-labeled tracers (e.g., 2-deoxy-2-
fluoro-D-glucose, FDG), a complex procedure with exposure to ionizing radiation. fMRI is 
primarily sensitive to deoxy-hemoglobin and suffers from slow imaging speed. Moreover, both 
87 
 
PET and fMRI are expensive techniques with poor spatial resolutions. Therefore, a fast, 
noninvasive and non-ionizing imaging modality with good spatial resolutions is needed to 
advance metabolism-associated studies of brain physiology and pathology.  
On the basis of the photoacoustic effect, photoacoustic tomography (PAT) solves the resolution 
drawback of pure optical imaging and the contrast drawback of pure ultrasonic imaging [5-7, 
192]. In PAT, photon energy absorbed by molecules is partially or completely converted into 
heat, which thermoelastically induces pressure waves. The induced pressure waves are detected 
by ultrasonic detectors to form an image [192]. PAT is capable of anatomical, functional, 
molecular and metabolic imaging of small animals, with highly scalable spatial resolution and 
penetration depth [6, 7, 193, 194]. Photoacoustic computed tomography (PACT) is a major 
implementation of PAT, which aims at fast data acquisition, sub-millimeter resolution and deep 
penetration depth beyond the optical diffusion limit [26, 195-197]. Noninvasive, label-free and 
functional PACT of the rat brain was demonstrated by accurately mapping brain lesions and 
cerebral hemodynamics [26]. Molecular imaging of a mouse brain tumor in vivo was also 
performed with PACT, using IRDye-800-c as the contrast agent [195].  
Here, for the first time, we have demonstrated that PACT is able to image glucose uptake in the 
mouse brain, using a newly developed glucose analog 2-deoxy-2-[N-(7-nitrobenz-2-oxa-1,3-
diazol-4-yl)amino]-D-glucopyranose (2-NBDG). To demonstrate the metabolic imaging 
capability of PACT, we studied in vivo forepaw stimulation responses. Our phantom and animal 
studies showed that PACT could spectrally separate 2-NBDG and blood using two-wavelength 
measurements, thus decouple the glucose and hemodynamic responses to the stimulations. Open-
scalp photoacoustic microscopy and fluorescence imaging were used to validate the results from 
PACT.  
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5.2.1.	Materials	and	methods	
2‐NBDG	
2-NBDG is a newly developed fluorescent 2-deoxyglucose (2-DG) analog [192, 198-205]. Like 
the FDG (molecular weight: 181) used in PET studies, 2-NBDG is transported into cells via the 
same GLUT as glucose [204]. Once taken up by cells, 2-NBDG is phosphatized to 2-NBDG-6-P, 
which prevents it from being released again from the cells. However, because of the lack of the 
2-hydroxyl group needed for glycolysis, 2-NBDG-6-P cannot be further metabolized. Therefore, 
the distribution of trapped 2-NBDG is a good reflection of glucose metabolism [203]. Because 2-
NBDG is a relatively small molecule (molecular weight: 342) (Fig. 1a), it crosses the blood-
brain-barrier much more easily than other near-infrared fluorophore-labeled 2-DG analogs, such 
as IRDye800-DG (molecular weight: 1330) [192, 199]. Moreover, 2-NBDG has its peak 
absorption at 478 nm, where hemoglobin has a much lower absorption [Figure 1b]. By carefully 
controlling the laser fluence, the signal contribution from hemoglobin can be neglected at this 
wavelength. These features have made 2-NBDG particularly suitable for brain studies. 
 
Figure	47.	2‐NBDG	 (C12H14N4O8).	 (a)	Chemical	 structure.	 (b)	Molar	 extinction	 spectra	of	2‐NBDG,	deoxy‐	
and	oxy‐hemoglobin.	
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Noninvasive	photoacoustic	computed	tomography	(PACT)	
Fig. 48a is the schematic of the PACT setup. An OPO laser (BasiScan 120, Spectra-Physics) is 
pumped by a Nd:YAG laser (Brilliant B, Quantel) with a third harmonic generator (355 nm) to 
provide pulses with wavelengths tunable from 420 nm to 680 nm. The pulse duration is 6 ns, and 
the pulse repetition rate is 10 Hz. The laser beam is homogenized by an optical diffuser (EDC-5, 
RPC Photonics) to provide uniform illumination over the mouse brain. The maximum light 
intensity at the tissue surface is approximately 10 mJ/cm2, below the ANSI limit at the chosen 
wavelengths. The photoacoustic signals are detected by a 5 cm diameter full-ring ultrasonic 
transducer array with 512 elements (Imasonic, Inc.). The central frequency of the ultrasonic 
transducer array is 5 MHz, and the 6-dB bandwidth is more than 80%. Each element in the array 
is directly shaped into an arc to produce an axial focal depth of 19 mm. The combined foci of all 
elements form a relatively uniform imaging region of 20 mm diameter and 1 mm thickness. 
Within this region, the axial (radial) resolution is 0.10 mm, and the transverse (tangential) 
resolution is 0.25 mm [206]. As show in Fig. 48b, after a complete data acquisition from all 512 
elements, the raw data is reconstructed to form a photoacoustic image of the brain based on the 
universal back-projection algorithm [207]. The imaging speed of the current system is 1.6 sec per 
frame. 
Optical‐resolution	photoacoustic	microscopy	(OR‐PAM)	
OR-PAM, another implementation of PAT, aims at capillary-level resolution within the optical 
diffusion limit [7, 32, 36, 39, 80, 81, 208]. As shown in Fig. 48c, by focusing the laser pulses to a 
diffraction-limit spot using an objective with an NA of 0.1 (AC127-050-A, Thorlabs), OR-PAM 
achieves a transverse resolution of 5 µm. By using a single-element ultrasonic transducer with a 
central frequency of 50 MHz and a 6-dB bandwidth of 100% (V214-BB-RM, Olympus-NDT), 
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OR-PAM achieves an axial resolution of 15 µm. Due to scattering by the tissue, the penetration 
depth of OR-PAM is limited to ~ 1 mm, which is sufficient for transcranial imaging of the 
cerebral cortex but not transdermal imaging. The arrival time of the PA signal provides depth 
information, and volumetric imaging is acquired by two-dimensional raster scanning of the 
sample. In this study, to validate the cortical vascular image obtained by PACT, the same mouse 
was imaged by OR-PAM at 570 nm after the PACT imaging. The scalp was surgically removed, 
while the skull was left intact. It took about 30 min to acquire an OR-PAM image over a 5×10 
mm2 area.  
Fluorescence	imaging	
To confirm the stimulation induced changes in 2-NBDG uptake in brain, open-scalp fluorescence 
imaging using the same experimental protocol was performed on a different mouse. The 
fluorescence imaging system shown in Fig. 48d has been reported previously [205]. Briefly, the 
light source is a 120-watt xenon arc lamp (Oriel Inc.) with an excitation filter (450 ± 20 nm, 
FB450-40, Thorlabs). Fluorescence images are captured by a low-noise CCD camera (Meade 
Inc.). An emission filter (550 ± 20 nm, FB550-40, Thorlabs) and an achromatic doublet (NT45-
265, Edmund) comprise the camera lens. In this study, the fluorescence images were acquired 
with a CCD exposure time of 0.5 sec. White-light images were acquired with a CCD exposure 
time of 0.05 sec after removing the emission filter and turning on the room light. Because blood 
vessels appeared darker than the background in the white-light images, the image intensity was 
reversed for better clarity.   
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Figure	48.	Photoacoustic	and	fluorescence	imaging	systems.	(a)	Schematic	of	the	PACT	system.	(b)	In	PACT,	
upon	 laser	excitation,	 the	 time‐domain	PA	signals	recorded	by	each	 transducer	element	are	back‐projected	
into	the	2D	imaging	space	based	on	the	delay	times,	and	then	summed	to	form	an	image	of	the	mouse	cortex.	
(c)	 Schematic	 of	 the	 OR‐PAM	 system,	 where	 the	 capillary‐level	 lateral	 resolution	 is	 provided	 by	 the	 tight	
optical	 focusing.	 UT,	 ultrasonic	 transducer;	 CorL,	 correction	 lens;	 RAP,	 right‐angled	 prism;	 RhP,	 rhomboid	
prism;	SOL,	silicone	oil	layer.	(d)	Schematic	of	the	fluorescence	imaging	system.	
Animal	preparation	
Female ND4 Swiss Webster mice (Harlan Laboratory, 16 to 20g) were used for the current study. 
The laboratory animal protocols for this work were approved by the Animal Studies Committee 
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of Washington University in St. Louis. To enhance 2-NBDG uptake, the mice were fast for 24 h 
before the experiment [204]. Before imaging, the hair on each mouse’s head was removed with a 
depilatory. An intraperitoneal dose of 90 mg/kg ketamine plus 10 mg/kg xylazine was used for 
anesthesia. The mouse was then taped to a lab-made animal holder, which was then mounted to 
the PACT system. Instead of being fully immersed in water, the animal was supported from 
below, with the head being covered by a flexible membrane. The entire experiment took less 
than one hour, therefore additional injection of the anesthetic mixture was not needed. The 
animal preparation for OR-PAM and fluorescence imaging were similar, except that there was no 
water coupling for fluorescence imaging. Three mice were used for PACT and subsequent OR-
PAM imaging, and one mouse was used for fluorescence imaging.     
Forepaw	stimulation	
Thirty minutes after the injection of 0.3 mL 3 mM 2-NBDG via the tail vein, stimulations were 
introduced by two pairs of needle electrodes inserted under the skin of the right and left forepaws, 
respectively. The electrodes were connected to a function generator (DS345, Stanford Research 
Systems) through a manual switch. The whole procedure consisted of four periods, each lasting 
for 3 min (Fig. 49a). The first and third periods (P1 and P3) were resting states, while the second 
period (P2) was right paw stimulation (RPS) and the fourth period (P4) was left paw stimulation 
(LPS). Each stimulation period consisted of a train of electrical pulses with an amplitude of 2 
mA, a pulse width of 0.25 sec and a repetition rate of 2 Hz (Fig. 49b). PACT acquired images 
continuously through the four periods. The procedure was first performed for 12 minutes at 478 
nm and then repeated for 12 minutes at 570 nm after a delay of 10 min. We assumed that brain 
responses were repeatable within the time window of the experiment.  
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Figure	 49.	 Time	 course	 of	 forepaw	 stimulation.	 (a)	 At	 each	 wavelength,	 the	 procedure	 consisted	 of	 four	
periods:	two	resting	periods	(P1	and	P3)	and	two	stimulation	periods	(P2	and	P4).	Each	period	lasted	for	3	
min.	(b)	Each	stimulation	period	consisted	of	a	train	of	electrical	pulses	with	an	amplitude	of	2	mA,	a	pulse	
width	of	0.25	sec	and	a	repetition	rate	of	2	Hz.				
Image	co‐registration	
Before quantitative analysis, the PA images at 570 nm from OR-PAM and PACT were co-
registered by using a MATLAB Image Processing Toolbox (R2010b, Mathworks, Boston, MA). 
Here, a 2D rigid registration was performed, which included linear translation, scaling, and 
rotation. The first step was to manually select 10-20 control points in the two images. The spatial 
translation, scaling and rotation matrix was computed based on the coordinates of these control 
points. The entire OR-PAM image was then transformed and registered to the PACT image 
using this matrix. To show the co-registration performance, the co-registered OR-PAM image 
was superimposed on top of the PACT image, with the overly transparency proportional to the 
OR-PAM image pixel values.  
Signal	processing	
In PACT, for both phantom and in vivo studies, the images acquired at 478 nm and 570 nm were 
used to reconstruct the distribution of 2-NBDG and hemoglobin, respectively. Since deoxy- and 
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oxy-hemoglobin have the same absorption coefficients at 570 nm, the PA signal amplitude was 
proportional to the total hemoglobin concentration HbC , an index for blood perfusion.  
For open-scalp OR-PAM, because the mouse skull is translucent, the attenuation of light due to 
the skull was neglected. The laser fluence measured at the skull surface is a good approximation 
of the actual fluence at the blood vessels. Therefore, HbC  can be estimated as [209] 
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k F . (12) 
Here, the subscript OR denotes the OR-PAM system and the superscript 570 denotes the 
wavelength. ORk is a calibration factor measured from blood in a clear medium, which 
incorporates the system detection efficiency and Grueneisen coefficient. 570Hb  is the molar 
extinction coefficient of hemoglobin at 570 nm, 570ORF is the laser fluence at the skull surface, and 
570
ORV  is the OR-PAM signal amplitude.  
Because PACT shares the same absorption contrast as OR-PAM, the calibrated HbC from OR-
PAM can be directly transferred to PACT once the images from the two systems are co-
registered. We estimate the calibration factor CTk  for PACT by 
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Here, the subscript CT denotes the PACT system. 570CTF  is the laser fluence measured at the scalp 
surface and 570CTV  is the PACT signal amplitude. In addition to the system detection efficiency 
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and Grueneisen coefficient, CTk  also incorporates an attenuation factor of the laser fluence at 570 
nm, which cannot be neglected in PACT owing to the scalp. 
The fluence attenuation of the scalp is wavelength dependent. However, the effective attenuation 
coefficients of the nude mouse scalp at 478 nm (7.1 cm-1) and 570 nm (6.5 cm-1) are 
approximately the same [210], and the mouse scalp is relatively thin (less than 1.5 mm) [211]. 
Therefore, the fluence attenuations at the two wavelengths were treated as the same. We also 
assumed that the heterogeneity of the scalp was negligible. Accordingly, we can estimate the 2-
NBDG concentration 2 NBDGC   as  
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  (14) 
Here, 4782 NBDG  is the molar extinction coefficient of 2-NBDG at 478 nm. 2 NBDG   is the 
conversion efficiency from absorbed optical energy to heat, which is 45% for 2-NBDG [212]. 
The conversion efficiency for hemoglobin is absent in Eq. 13 because it is 100%.  
Eqs. (12-14) can be used to estimate the absolute concentrations of hemoglobin and 2-NBDG in 
the brain. Because the absolute baseline signals vary across the brain, relative changes are more 
robust for quantifying the responses induced by stimulations. However, it is also important to 
demonstrate the absolute imaging capability of PACT, which is useful for the baseline mapping. 
In addition, the future quantification of the metabolic rates of oxygen and glucose requires the 
absolute concentrations.  
In forepaw stimulations, PACT images acquired during each period (P1-4) were averaged at each 
wavelength to increase the signal-to-noise ratio. The relative changes were computed as (P2 – P1) 
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/ P1 for RPS, and as (P4 – P3) / P3 for LPS. Only pixels with amplitude above 1.5 times the noise 
level were used for calculation. In response quantifications, only pixels with response magnitude 
above 10% of the maximum magnitude were averaged. The same procedure was also applied to 
the fluorescence imaging results. 
Response areas at the two wavelengths were also quantified. Here, the response area was defined 
by the pixels with a response magnitude above 10% of the maximum response magnitude. The 
cortical area covered by the responding vessels was estimated as well. An ellipse equation was 
used to fit the outline of the responding vessels, with the center, major axis, minor axis and 
orientation as the fitting variables. The area of the best fit ellipse was approximated as the 
covered area.    
5.2.2	Results	
PACT	of	2‐NBDG	and	blood	phantom	
A phantom study was first performed to validate the spectral separation of 2-NBDG and blood. 
As shown in Fig. 50a, whole bovine blood (hemoglobin concentration: 2.5 mM) and 0.4 mM 2-
NBDG solution were embedded in gelatin and imaged by PACT at 478 nm and 570 nm. This 2-
NBDG concentration was close to the estimated 2-NBDG concentration in animal studies to be 
performed later. The ratios between the averaged PA signal amplitudes of 2-NBDG and blood at 
478 nm and 570 nm were 9:1 and 0.06:1, respectively (Fig. 50b). Blood was almost invisible at 
478 nm, so was 2-NBDG at 570 nm. The PA amplitude of the 2-NBDG sample happened to be 
nearly identical to (0.98 times) that of the blood sample at 570 nm. Therefore, 2-NBDG and 
blood could be separated as shown in Fig. 50c. In addition, we found that 2-NBDG was more 
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diffusive than hemoglobin (molecular weight: 64,458) in gelatin, due to the much smaller size of 
2-NBDG molecules.  
 
Figure	50.	Multi‐wavelength	PACT	 in	vitro	 and	 in	vivo.	 (a)	Photograph	 (left)	 and	PACT	 images	 (middle	 and	
right)	of	whole	bovine	blood	and	0.4	mM	2‐NBDG	 in	a	gelatin	phantom.	 (b)	Averaged	PA	amplitudes	 from	
blood	 and	 2‐NBDG,	 normalized	 by	 the	 PA	 amplitude	 of	 blood	 at	 570	 nm.	 (c)	 Spectral	 separation	 of	 blood	
(shown	 in	 red)	 and	 2‐NBDG	 (shown	 in	 blue).	 CHb:	 total	 hemoglobin	 concentration;	 C2‐NBDG:	 2‐NBDG	
concentration.	(d)	Photograph	of	a	mouse	brain	with	its	scalp	intact	(top)	and	removed	(bottom).	SS:	sagittal	
sinus;	 CS	 coronal	 suture.	 (e‐f)	 PACT	 images	 of	 the	mouse	 brain	 at	 (e)	 2‐NBDG‐dominant	 478	 nm	 and	 (f)	
hemoglobin‐dominant	 570	 nm,	 respectively.	 (g)	 Spectral	 separation	 of	 blood	 (shown	 in	 red)	 and	 2‐NBDG	
(shown	in	blue)	in	the	brain.	
PACT	of	mouse	brain	
Figs. 50e-f are noninvasive PACT images of a mouse brain, acquired 30 min after 2-NBDG 
administration. At 478 nm, the PA signal amplitudes reflected the 2-NBDG concentration in the 
brain tissue (Fig. 50e). At 570 nm, the PA signal amplitudes reflected the total hemoglobin 
concentration in blood vessels (Fig. 50f). Cortical vascular landmarks including the sagittal sinus 
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(SS) and coronal suture (CS) were clearly imaged by PACT and confirmed by open-scalp 
photography. A merged image of CHb and C2-NBDG is shown in Fig. 50g, where 2-NBDG signals 
from blood vessels were excluded. The hemoglobin distribution was superimposed on top of the 
2-NBDG distribution, with the transparency of the hemoglobin layer proportional to its pixel 
values. Capillary-level OR-PAM images of the same mouse are shown in Figs. 51a-b. The co-
registration results show that the transdermal and transcranial PACT image agreed well with the 
open-scalp OR-PAM image, as shown in Fig. 51c-d.  
 
Figure	51.	High‐resolution	OR‐PAM	imaging	of	the	mouse	brain	after	PACT	imaging.	(a)	OR‐PAM	image	of	the	
mouse	 brain,	 acquired	 at	 570	 nm	with	 the	 scalp	 removed	 and	 the	 skull	 left	 intact.	 CHb:	 total	 hemoglobin	
concentration;	 SS:	 sagittal	 sinus;	 CS:	 coronal	 suture.	 The	 numbers	 denote	 representative	 control	 points	
selected	 for	 image	 co‐registration.	 (b)	 Close‐up	 of	 region	 inside	 the	 dashed	 box	 in	 (a)	 showing	 the	 dense	
capillaries	 in	 the	brain	cortex.	CP:	capillary.	 (c)	PACT	 image	of	 the	same	mouse	brain	with	 intact	scalp	and	
skull.	The	numbers	denote	the	control	points	corresponding	to	those	in	(a).	(d)	Co‐registered	OR‐PAM	image	
(shown	in	color)	superimposed	on	the	PACT	image	(shown	in	gray).	
PACT	of	cortical	responses	to	forepaw	stimulations	
Fig. 52a-b are the relative changes of PA signals induced by forepaw stimulations. At 478 nm 
(Fig. 52a), the RPS and LPS caused PA signal amplitudes to increase by 3.6% ± 2.2% and 2.0% 
± 1.1% in the somatosensory region (SR) of the contralateral hemisphere, respectively. Such 
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increases indicate elevated glucose uptake rates, and thus reflect increased neuron activity. Under 
the two stimulations, the response areas were 5.7 ± 1.3 mm2 and 7.4 ± 2.5 mm2, respectively.  
 
Figure	 52.	 PACT	 of	 the	 cortical	 responses	 to	 forepaw	 stimulations.	 (a‐b)	 Relative	 changes	 of	 the	 PA	
amplitudes	 (shown	 in	 color)	acquired	at	 (a)	2‐NBDG‐dominant	478	nm	and	 (b)	hemoglobin‐dominant	570	
nm	under	the	right	paw	stimulation	(RPS)	and	left	paw	stimulation	(LPS),	superimposed	on	the	resting‐state	
image	 (shown	 in	 gray).	 The	 threshold	 for	 the	 overlay	 transparency	 was	 set	 to	 be	 10%	 of	 the	 maximum	
response.	 (c)	Overlaid	 images	 showing	 the	 relative	 changes	of	 2‐NBDG	 concentration	 (C2‐NBDG,	 shown	 in	
blue)	and	total	hemoglobin	concentration	(CHb,	shown	in	red),	superimposed	on	the	resting‐state	 image	at	
570	nm	 (shown	 in	 gray).	 (d)	Relative	 changes	of	C2‐NBDG	and	CHb	averaged	over	 three	mice.	Error	bars:	
standard	deviation.	The	p	values	were	calculated	from	paired	Student’s	t‐test	between	stimulated	states	P2	or	
P4	and	resting	states	P1	or	P3.	
Similarly, at 570 nm (Fig. 52b], the RPS and LPS caused PA signal amplitudes to increase by 6.4% 
± 5.3% and 3.2% ± 2.9% in the contralateral hemisphere, respectively. Such changes indicate an 
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increase in total hemoglobin concentration arising from elevated inflows of fresh blood, and thus 
reflect increased neuron activity as well. Under the two stimulations, the response areas were 4.7 
± 1.5 mm2 and 4.5 ± 1.2 mm2, respectively. Furthermore, the responding vessels covered much 
larger cortical regions of 16.5 ± 3.3 mm2 and 15.1 ± 2.5 mm2, respectively, as shown in Fig. 53a. 
The areas covered by the responding vessels were significantly wider than the 2-NBDG response 
areas for both RPS and LPS, with p values less than 0.05 (Fig. 53b). 
 
Figure	53.	Quantification	of	the	cortical	region	covered	by	responding	vessels.	(a)	An	ellipse	was	used	to	fit	
the	 outline	of	 the	 responding	vessels,	with	 the	 center,	major	 axis,	minor	 axis	 and	orientation	as	 the	 fitting	
variables.	(b)	Quantification	of	hemoglobin	response	area,	2‐NBDG	response	area	and	cortical	region	covered	
by	responding	vessels,	averaged	over	three	mice.	Error	bars:	standard	deviation.	The	p	values	were	calculated	
from	 paired	 Student’s	 t‐test	 between	 the	 2‐NBDG	 response	 area	 and	 the	 cortical	 region	 covered	 by	
responding	vessels.	
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In addition, the linear regression shows that the 2-NBDG response amplitude was approximately 
proportional to that of the hemoglobin response for both RPS and LPS, with ratios of ~0.48 and 
~0.52, respectively (Fig. 54a). Similarly, the ratios between the 2-NBDG response area and the 
area covered by the responding vessels were ~0.41 and ~0.57 for RPS and LPS, respectively (Fig. 
54b). The high correlation of the two responses may reflect the close coupling between oxygen 
metabolism and glucose metabolism in the brain.   
 
Figure	54.	Correlation	of	 the	hemodynamic	 response	and	glucose	 response.	 (a)	Linear	 regression	of	 the	2‐
NBDG	response	amplitude	and	the	hemoglobin	response	amplitude	for	RPS	and	LPS	on	three	mice.	(b)	Linear	
regression	of	the	2‐NBDG	response	area	and	cortical	area	covered	by	responding	vessels	for	RPS	and	LPS	on	
three	mice.	
Fluorescence	imaging	of	cortical	responses	to	forepaw	stimulations	
First, whole bovine blood and 2-NBDG (0.4 mM) were enclosed in 1 mm diameter glass tubes 
and imaged by our fluorescence setup (Fig. 55a). The fluorescence image shows that blood did 
not generate fluorescence while 2-NBDG did profusely.  
0 5 10 15 20 25
0
2
4
6
8
10
12
LPS
RPS
Cortical region covered by
responding vessels (mm2)
2-
N
B
D
G
 re
sp
on
se
 a
re
a  
(m
m
2 )
0 2 4 6 8 10 12 14
0
2
4
6 RPS
LPS
Relative change in CHb (%)
R
el
at
iv
e 
ch
an
ge
 in
 C
2-
N
B
D
G
(%
)
(a) (b)
y  0.48x
R2  0.96
y  0.52x
R2  0.76 y  0.57x
R2  0.74 y  0.41x
R2  0.97
102 
 
Second, using the same experimental protocol as in PACT, we imaged the cortical responses to 
forepaw stimulations on a different mouse using the fluorescence setup. The results are shown in 
Fig. 55b. While the white light image shows the detailed cortical vasculature, the fluorescence 
image shows the 2-NBDG distribution and thus the glucose metabolism. The RPS and LPS 
induced fluorescence intensity to increase by 5.1% and 6.2% in the SR of the contralateral 
hemisphere, respectively. Such increases indicate elevated glucose uptakes in the SR, which 
qualitatively agree with the glucose responses assessed by PACT.  
 
Figure	 55.	 Fluorescence	 imaging	 of	 mouse	 brain	 responses	 to	 forepaw	 stimulations.	 (a)	 Left:	 intensity‐
reversed	white‐light	 image	of	 two	glass	 tubes	 filled	with	2‐NBDG	(0.4	mM)	and	whole	bovine	blood.	Right:	
fluorescence	 image	of	 the	 two	 tubes.	 (b)	Relative	 changes	of	 the	 fluorescence	 intensity	under	RPS	and	LPS	
(shown	 in	 color),	 superimposed	 on	 the	 intensity‐reversed	white‐light	 image	 of	 the	 brain	 cortex	 (shown	 in	
gray),	with	the	scalp	removed	and	skull	left	intact.	The	threshold	for	the	overlay	transparency	was	set	to	be	
10%	of	the	maximum	response.					
5.2.3.	Conclusions	and	discussion	
The pathways of oxygen metabolism and glucose metabolism are closely coupled in neuron 
activity. One of the recent uses of PACT is the label-free measurement of metabolic rate of 
oxygen (MRO2) [5, 39]. Currently, except for blood flow speed, PACT can measure all the other 
parameters required for quantifying MRO2, namely vessel cross-section, oxygen saturation and 
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total concentration of hemoglobin, and tissue volume. Recently, a few PA methods have been 
proposed for blood flow measurement in deep tissue, which may be applicable to PACT [76-78, 
213]. Therefore, PACT has the potential to simultaneously image the two metabolic pathways: 
oxygen metabolism as described by others, and glucose metabolism as shown in this paper.  
Previous studies by PET and fMRI have shown that forepaw stimulations can increase the 
cerebral metabolic rate of oxygen (CMRO2) [214-216]. Because the blood oxygenation change is 
much smaller than the blood flow change, such increase in CMRO2 is mainly attributed to the 
elevated blood perfusion [214-216]. In our results, the intensified photoacoustic signal at 570 nm 
provided a direct evidence of the increase in blood perfusion. For absolute CMRO2 quantification, 
our future work will incorporate the oxygenation measurement by using multiwavelength 
measurements. 
In addition, we found that the glucose response area was confined within the SR, while the 
hemodynamic response area was much larger than that. Glucose response was a focal activity 
restricted to neurons responsible for the stimulated site. In contrast, hemodynamic response was 
less spatially restricted since fresh blood must be delivered from the major feeding arteries, 
through the capillaries of the SR, to the major draining veins. Moreover, the hemodynamic 
response may spread into neighboring vessels of the same vascular network.  
Except for the dimensional discrepancy, the glucose response area was more homogenous than 
the hemodynamic response area. The latter was characterized by a strong vascular pattern. 
Moreover, there was a clear core for the glucose response, which is indicated by the double 
arrows in Fig. 52a. Such a core was not seen in the hemodynamic response. This again suggests 
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that glucose response was a focal activity. The core region contained the neurons most sensitive 
to the stimulated site.     
In summary, using 2-NBDG as the exogenous contrast and hemoglobin as the endogenous 
contrast, we have demonstrated that PACT is capable of imaging the metabolic response of a 
mouse brain to forepaw stimulations. As a quantitative imaging modality, PACT can spectrally 
separate 2-NBDG and hemoglobin by virtue of its optical absorption contrast. As a fast imaging 
modality, PACT can acquire a volumetric image in less than two seconds with a laser repetition 
rate of 10 Hz. This imaging speed can be further improved by a laser system with higher 
repetition rate and automatic wavelength switch. As a deep imaging modality, PACT can 
transdermally and transcranially localize the spatial patterns of the brain responses by virtue of 
its high ultrasonic resolution. With all these merits, we expect PACT to be applied to more brain 
metabolism studies in the future. 
6.	Future	work	
PAM has the following notable features: (1) PAM has highly scalable spatial resolution and 
maximum imaging depth in both the optical and acoustic domains. (2) PAM images optical 
absorption contrast with 100% sensitivity, and provides images without speckle artifacts. (3) 
PAM can essentially image all molecules at their absorbing wavelengths. (4) PAM is capable of 
functional and metabolic imaging in absolute units using endogenous contrast agents.  
As in modern optical microscopy, it is possible to combine multiple optical objectives with 
different magnification powers to a single OR-PAM system for fast resolution switching. 
However, the confocal alignment of the optical illumination and acoustic detection needs to be 
maintained. Typically, a microscope objective with a higher NA comes with a shorter focal 
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length. To keep the imaged object in focus, one solution is to use a specially designed parfocal 
lens, which is capable of varying the effective NA without changing the optical focal length. 
Similarly, it is also possible to integrate multiple ultrasonic transducers with different central 
frequencies into a single AR-PAM system, while keeping the same illumination. Furthermore, 
OR-PAM can be combined with AR-PAM as a single device to cover a wider scale range. Since 
OR-PAM and AR-PAM can share the same detection, only the optical illumination needs to be 
integrated.   
Integration between PAM and other imaging modalities can provide complementary contrasts, 
thus is a direction for future PAM development. So far, PAM has been integrated with back-
scattered optical microscopy (scattering contrast) [217], fluorescence microscopy (fluorescence 
contrast) [132, 158, 218], optical coherence tomography (scattering contrast) [132, 219], two-
photon microscopy (fluorescence contrast) [220] and pulse-echo ultrasound imaging (mechanical 
and elastic contrast) [221, 222]. In these integrated systems, the two sub-systems share either the 
same illumination or detection. Therefore, their images are inherently co-registered. In addition 
to providing complementary contrast, PAM has been combined with a high intensity focused 
ultrasound (HIFU) system for therapeutics, where PAM is used to outline the location and shape 
of tumors and guide the subsequent HIFU therapy or drug release [145, 223]. In addition to the 
integration of instrumentations, new exogenous contrast agents have also been integrated for 
multi-modal systems. For example, perfluorocarbon nanoparticles loaded with near-infrared dyes 
have been used as a dual contrast agent for fluorescence imaging and PAM imaging [224].  
Another direction is to miniaturize the PAM system for internal organ and intravascular imaging 
[168, 225-231]. The first sideway looking photoacoustic endoscope (PAE) with a 4.2-mm-
diameter probe has been demonstrated in acoustic-resolution mode for functional esophagus and 
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colon imaging on small animal models [225, 227]. The bottleneck for further miniaturization of 
the PAE probe involves integrating the light delivery fiber with a conventional piezoelectric 
transducer. Despite the complex fabrication procedures for miniature piezoelectric detector, its 
detection sensitivity decreases with its size. By contrast, optical detection of ultrasound pressure 
using a transparent Fabry-Perot sensor may be an alternative solution [232]. Theoretically, PAE 
should enjoy the same scalability as PAM. Since most cancers start from the epithelial layer, 
PAE can be implemented in optical-resolution mode for high-resolution epithelial imaging of 
early-stage cancer [225-227]. Delivery of coupling medium for acoustic propagation remains 
another challenge for PAE imaging of internal lumens such as the trachea and gastrointestinal 
(GI) tract. It has been suggested that water and ultrasound gel can be introduced to the GI tract 
[226, 227]. However, it is challenging to apply water to the respiratory system. An inflatable 
balloon with a water filling channel could be a solution [233]. By contrast, it is less problematic 
for intravascular PAE imaging since blood is a natural acoustic coupling medium. However, the 
strong absorption of blood in the visible spectral range requires the use of near-infrared 
wavelengths. Alternatively, blood can be flushed with saline.  
As a maturing imaging technique, PAM is expected to find new applications in both fundamental 
life science and clinical practice, which include but are not limited to tumor angiogenesis, 
lymphatic dynamics, neural activity, brain metabolism, cancer detection, drug delivery and 
intraoperative monitoring. While PAM has been commercialized for pre-clinical applications, 
future commercialization for clinical applications will greatly accelerate the translation of PAM 
from a lab technology to a mainstream imaging modality.  
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